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Abstract 
Super-resolution fluorescence microscopy has great potential in biological 
imaging, especially for the sophisticated visualization of sub-cellular structures that are 
smaller than the diffraction limit (~200 nm). Most super-resolution microscopy techniques 
require photo-responsive fluorescent probes. However, current fluorescent probes (i.e., 
fluorescent proteins and molecular dyes) suffer from insufficient brightness and low 
stability, which limits the application of super-resolution imaging for long term observation 
of biological processes. 
Quantum dots (QDs) are semiconductor nanocrystals that emit fluorescence upon 
excitation. Compared with fluorescent proteins and molecular dyes, QDs are more stable 
and brighter. Moreover, QDs have been successfully applied in imaging cells, tissues, and 
living animals. Therefore, designing stable and bright photo-switchable QDs could make a 
substantial contribution to super-resolution imaging. 
A few types of photo-switchable QDs have been developed. Mn-doped ZnSe QDs 
are photo-switchable, and have been applied in super-resolution techniques. However, 
modulation of these QDs requires a high power laser (i.e., ~2 MW/cm2), the optical 
properties of these QDs are inferior to conventional CdSe/ZnS QDs, and the switching 
behavior of these QDs is not stochastic, thus making them suitable for only some types of 
super-resolution imaging techniques. Other types of photo-switchable QDs suffer from 
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insufficient bright/dark contrast, low stability, or slow transition between bright/dark 
states. 
This dissertation includes two aspects of research. First, we synthesized photo-
switchable Mn-doped ZnSe QDs in the organic phase (deterministic switching), and 
improved their optical properties and photo-stabilities by micelle encapsulation. We also 
investigated our micelle coating platform on conventional CdSe/ZnS QDs, which also 
exhibited similar enhanced properties. In addition, we examined the impact of micelle 
encapsulation on cytotoxicity, and showed that our micelle coating could significantly 
reduce the toxicity of CdSe/ZnS QDs. Surprisingly, the loss of cell viability was not caused 
by the generation of reactive oxygen species (ROS), and the cell death was not caused by 
apoptosis. 
 In a separate approach, we designed a novel type of photo-switchable QDs. This 
design was primarily based on gold nanoparticle (AuNP) quenching of QD fluorescence 
via Förster resonance energy transfer (FRET) and azobenzene-modified DNA linkers for 
photo-switching. These QDs are intrinsically different from the ones previously reported 
in the literature, which had deterministic on/off kinetics, and cannot be used in Stochastic 
Optical Reconstruction Microscopy (STORM). By using a highly efficient quencher 
(AuNP), our design eliminated the need for multiple quenchers per QD, and therefore had 
the potential to be modulated on/off stochastically, a prerequisite for STORM. 
 Lastly, we obtained preliminary results for nanoparticles-DNA origami conjugates 
(hinge), which has the potential to be used in developing nano-machines that have multi-
functionality from the nanoparticles, and precise spatial configurations. 
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Chapter 1:  Introduction 
Super-resolution fluorescence microscopy has great potential in biological 
imaging, especially for the sophisticated visualization of sub-cellular structures that are 
smaller than the diffraction limit (~200nm) [1]. Most super-resolution microscopy 
techniques require photo-responsive fluorescent probes. However, current fluorescent 
probes (i.e., fluorescent proteins and molecular dyes) suffer from insufficient brightness 
and low stability, which limits the application of super-resolution imaging for long term 
observation of biological processes. 
Quantum dots (QDs) are semiconductor nanocrystals that emit fluorescence upon 
excitation. Compared with fluorescent proteins and molecular dyes, QDs are more stable 
and brighter. Moreover, QDs have been successfully applied in imaging cells, tissues, and 
living animals [2]. Therefore, designing stable and bright photo-switchable QDs could 
make a substantial contribution to super-resolution imaging. 
 
1.1 Super-resolution imaging 
1.1.1 Conventional fluorescence microscope 
Fluorescence microscopy is an optical microscopy method that acquires signals 
from emitted fluorescence in contrast with reflection or absorption of light. It is widely 
used to observe biological structures and processes, especially at the cellular and 
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subcellular levels. Compared with electron microscopy (EM), fluorescence microscopy 
offers a less invasive and real time approach to observe biological systems. Moreover, 
fluorescence microscopy can apply target-specific fluorescence probes, which enable 
specific imaging of the cells or molecules of interest [1]. 
However, the resolution of conventional fluorescence microscopy is constrained by 
a diffraction limit (~200nm), as described by Abbe’s law: d =
λ
2n sin α 
, in which λ is the 
light wavelength, n is the refractive index of medium, and α represents the half-angle 
subtended by the optical objective lens. This is mainly because the diffraction functions of 
adjacent fluorophores (with a distance smaller than λ/2n) overlap with each other and make 
them indistinguishable [1, 3]. 
 
1.1.2 Super-resolution imaging 
Over the last few decades, researchers have investigated several approaches to 
improve the resolution of fluorescence imaging. The resolution of images acquired directly 
from the microscope remains constrained by the diffraction limit, yet researchers are able 
to extract more detailed spatial information by applying photo-switchable fluorophores, 
advanced algorithms, and/or sophisticated illumination patterns, to reconstruct images of 
higher resolution (i.e., ~20 nm in lateral dimension and ~50 nm in axial dimension) [1]. 
The most promising techniques can be categorized into three groups. The first 
group applies the strategy of single molecule localization, and is represented by Stochastic 
Optical Reconstruction Microscopy (STORM) [4], Photoactivatable Localization 
Microscopy (PALM) [5], Fluorescence Photoactivation Localization Microscopy 
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(FPALM) [6], and direct Stochastic Optical Reconstruction Microscopy (dSTORM) [7]. 
These techniques share the same principle: the position of one fluorophore can be 
determined precisely if all the adjacent fluorophores are switched off (center of the 
emission pattern, or “Airy disk”). Figure 1 represents the basic idea of STORM imaging: 
the sample of interest is represented with a hypothetical hexametric object labeled with 
fluorophores (red dots), and these dots can be quenched by a red laser pulse (black dots), 
so that the remaining fluorophores can be localized with high precision (white cross) 
without interference from neighbors. 
 
 
Figure 1: Principle of the strategy of single molecule localization (STORM) adapted from 
[4] 
 
The second group uses an ensemble approach, and includes Stimulated Emission 
Depletion (STED) [8] and Group State Depletion (GSD) [9]. This strategy also shares the 
principle that the position of individual fluorophores can be accurately determined. 
However, instead of switching fluorophores stochastically, these techniques apply 
sequential readout (the same as in a confocal microscopy), focus on a small ensemble of 
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fluorophores at a time, and use a well-designed illumination/modulation laser pattern 
(Figure 2) to suppress the adjacent fluorophores. 
 
 
Figure 2: Scheme of STED excitation, modulation laser pattern, and the effective 
fluorescence spot. (http://www.nature.com/news/2009/090603/full/459638a/box/1.html) 
 
The third group includes Saturated Pattern Excitation Microscopy (SPEM) [10] and 
Saturated Structured Illumination Microscopy (SSIM) [11]. In this strategy, the spatial 
information of the sample is transferred into frequency space through Fourier transform, 
and the highest resolution corresponds to the maximum observable frequency. Applying a 
structured illumination light with certain frequency can expand the maximum observable 
frequency by forming a Moiré fringe pattern, thus increasing the resolution. In recent years, 
super-resolution microscopy techniques have been extended to 3D [12-14] and multi-color 
imaging [14-16], and have been successfully applied in biological systems [1].  Moreover, 
some of these techniques have been commercialized: e.g., STORM from Nikon and from 
Zeiss, STED from Leica, and SIMM from Zeiss. 
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1.1.3 Conventional fluorescence probes 
Most of the techniques (i.e., STORM, STED and their derived methods) in the first 
and second groups require fluorophores to be switched on/off by a modulation light source 
(in the presence of a second excitation light source). Also, high resolution imaging 
demands a high signal to noise ratio (SNR). Therefore, an ideal fluorophore should have 
good brightness and a dramatic contrast between on/off states to enable a desired SNR. In 
addition, these fluorophores should possess sufficient stability to be observed over a long 
duration. 
Most super-resolution fluorescent microscopy techniques apply either fluorescent 
proteins or molecular dyes as the fluorescent probes [16]. Fluorescent proteins (FPs) have 
the advantage of good targeting specificity, but they suffer from instability in light and 
unsatisfactory brightness. Even the brightest FP, Monomeric Eos, can only emit ~490 
photons per molecule before photobleaching, which is the destruction of fluorophore 
through photochemical approach [17]. Additionally, fluorescent proteins are generally 
manufactured by the organism in question, requiring transfection before observation can 
be performed. Molecular dyes are generally more stable and brighter than fluorescent 
proteins, and some dyes can emit as many as 6000 photons before photobleaching [14]. 
However, applying super-resolution imagining in vivo is difficult because of increased 
background noise and aberrations generated by tissue [18]. Other than efforts directed 
toward optical aberration correction, more stable and brighter fluorescent probes are 
required to achieve high-quality images in vivo.  
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1.2 Overview of quantum dots 
1.2.1 Principles 
In semiconductor materials, the valence band (VB) contains the highest range of 
energy states available to electrons when they are bound to atoms, and the conduction band 
(CB) contains the lowest range of vacancy energy states. The energy difference between 
the highest VB and the lowest CB is the band gap energy. An electron can be excited from 
the VB to the CB by absorbing energy higher than the band gap energy, leaving behind a 
positively charged region, called a “hole”. The Coulombical coupled electron and hole are 
described as an “exciton”. In QDs, the mathematical radius of the exciton is smaller than 
the size of the nanocrystal, and the exciton is restricted by the boundary of the nanocrystal 
(quantum confinement), therefore the energy of the exciton is affected by the size of the 
nanoparticle, and the band gap energy increases with the decrease of nanocrystal diameters 
[17]. 
When photons are used to excite QDs and another photon of lower frequency is 
released, QDs exhibit photoluminescence. Most QD applications in biology utilize this 
property for cellular/molecular tracking and imaging [2]. When a photon excites a QD, but 
the energy is captured in the form of electricity, the QD is used as a photovoltaic material 
and is a candidate for solar cells. In addition, electricity of higher voltage can also separate 
electrons from holes to form excitons, and when the energy is released in the form of light, 
QDs are used in LEDs. In addition, QDs can be used as a medium for photon propagation, 
and because of their relatively low temperature dependency, QD- based lasers can be used 
at higher temperatures than their conventional counterparts. 
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1.2.2 Quantum dots vs. molecular dyes  
QDs have many advantages over molecular dyes/FPs as fluorescent probes [18]. 
First of all, QDs are much brighter on an individual particle basis. This is mainly because 
QDs can absorb more excitation photons (i.e., have a higher absorption cross-section), and 
also have a good quantum yield (the ratio between emitted photons and absorbed photons), 
i.e., near unity quantum yield QDs have been developed [19]. 
Second, QDs are more stable against photobleaching. Researchers have compared 
quantum dots with conventional dyes (e.g., Texas red) [20], as well as some newly 
developed molecular dyes (e.g., Alexa 594) [21], and shown that QDs are significantly 
more stable than molecular dyes. 
In addition, QDs have other superior optical properties including broad excitation 
spectra, narrow emission spectra, and tunable emission peaks. The broad excitation spectra 
enable QDs to be excited at a wavelength far from their emission peaks, which efficiently 
minimizes background scattering. Narrow emission spectra and tunable emission peaks 
provide the basis for multi-channel imaging, since QDs with different emission peaks can 
be observed in different channels, without interference from other QDs [18]. In addition, 
QDs show intermittent fluorescence (blinking) and light-induced emission spectra blue 
shifting (blueing). These properties will be discussed in the following section. 
The major concern of using QDs for in vivo application is their toxicity [22]. 
Conventional QDs contain toxic elements (i.e., Cd) that can be released to the environment 
as QDs degrade. In addition, QDs toxicity shows a strong correlation with size and surface 
ligands. Nevertheless, novel Cd-free QDs have been synthesized (e.g., Mn-doped ZnSe 
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QDs) and advanced surface coatings have been developed to reduce toxicity. Recent study 
of phospholipid-PEG coated CdSe/ZnS QDs on non-human primates showed no adverse 
response for one year, suggesting QDs toxicity can possibly be circumvented or at least 
mitigated [23]. 
The other problem in the application of QDs in in vivo imaging is that typical QDs 
have larger sizes (15~20 nm) compared with molecular dyes (~0.5 nm) and FPs (several 
nanometers). This property increases the difficulty of delivering QDs into living cells, and 
raises the risk of interfering with target biological processes. This problem is partially 
solved by advanced delivery methods. For example, conjugating QDs with cell penetrating 
peptides (CPP), certain proteins, or polymers can facilitate delivery. Alternatively, QDs 
can penetrate the cell membrane through active delivery methods including 
electroporation, microinjection, and gene gun delivery [24]. Moreover, in recent years 
researchers have adopted novel surface coating strategies and produced QDs as small as 
~5 nm in hydrodynamic diameter, as will be discussed in Chapter 2.  
 
1.3 Quantum dots in super-resolution imaging 
1.3.1 Doped QD 
A few photo-responsive QDs have been designed, but only Mn-doped ZnSe QDs 
(doped QDs) have been studied in super-resolution imaging. [25] These QDs can be 
switched on and off by light modulation. As mentioned above, the fluorescence of doped 
QDs does not directly correspond to the band gap between the VB and the CB. Instead, 
emission in doped QDs is produced from intermediate energy levels. For example in Mn-
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doped ZnSe: 4T1 (triple state) to 
6A1 (singlet state) transitions. Therefore, a modulation 
beam can “pump” electrons from 4T1 to the CB, thus switching off the doped QDs (Figure 
3). 
 
Figure 3: Photo-modulation mechanism of Mn-doped QDs [25] 
 
Although doped QDs have shown potential in super-resolution imaging, they have 
several limitations. First, the photo-switching process is deterministic, so these doped QDs 
are not transferrable to single molecule localization strategies that require stochastic 
switching between dark and bright states. Second, the intensity of the modulation beam 
used has been as high as 1,900,000 W/cm2, compared with the 30 W/cm2 modulation beam 
used in STORM [4]. This high energy intensity may cause damage to tissues and live 
animals. Third, the optical properties of doped QDs are inferior to those of conventional 
CdSe/ZnS quantum dots. For example, the emission peak of doped QDs can only be tuned 
from 565 nm to 610 nm and its full width at half maximum (FWHM) is ~ 52 nm [26], 
whereas the emission peak of CdSe/ZnS QDs ranges from violet to red, and the FWHM is 
~22-25 nm. 
10 
 
1.3.2 Blueing 
Blueing describes the continuous blue shift of QD emission spectra upon steady 
illumination. This process results from the photo-induced oxidation of the nanocrystals and 
the formation of an evaporating surface oxide film. Since smaller QDs have a stronger 
quantum confinement, which increases the electron-hole pair energy, the released photon 
is “bluer” as a result of dissolution of the surface oxide layer [27, 28]. 
QD blueing has been used in super-resolution imaging with the single molecule 
localization strategy, and a resolution of 12 nm has been achieved. The emission filter is 
set to a wavelength region slightly blue-shifted from the original QD emission wavelength 
range. At first no fluorescence signal is observed, and then some of the QDs will enter this 
region because of blueing. After readout, these QDs will leave this region, i.e., their 
fluorescence is blue-shifted relative to the observation window, and other QDs will appear 
[29].  
This method has significantly increased the application of QDs in super-resolution, 
and has recently been extended to multicolor 3D imaging [30]. Nonetheless, photo-blueing 
is an irreversible process, and each QD can only be localized once. Therefore this method 
does not enable observation of dynamic, biological processes at super-resolution. Another 
concern arise from the mechanism of blueing, which is a deliberate destroying of QD 
surface, and since the inorganic ligands are directly attached to QD surface, they may 
detach from the QD surface (but still remain attached to the biomolecules of interests). As 
a result, QDs may slightly diffuse away from the targets, and the super-resolution imaging 
may reflect the positions of QDs but not the biomolecules. 
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1.3.3 Blinking 
QDs show a stochastic transition between the fluorescent (bright) state and non-
fluorescent (dark) state, which is referred to as intermittent fluorescence, or blinking. When 
QDs are in dark states, the fluorescence approaches zero, which yields a high bright/dark 
contrast. Sometimes the camera captures intermediate fluorescence intensity between 
bright state and dark state, yet this signal is attributed to a lack of temporal resolution [17]. 
In the conventional blinking model, the non-fluorescent state corresponds to a 
charged nanocrystal. When the excited electron returns to the ground state, the energy is 
used to excite another electron and is dissipated through a non-fluorescent pathway (Auger 
mechanism). Recently, a different type of blinking mechanism was proposed. This model 
suggests that the excited electron is captured by a recombination center, which quenches 
the fluorescence (hot electron theory) [31]. 
Blinking is beneficial in recognizing individual QDs from aggregated QD clusters, 
since blinking is averaged out in large, aggregated clusters. However, for dynamic particle 
tracking, blinking causes a loss of fluorescence signal, and it is difficult to distinguish 
blinking from out-of-focus motion [32]. 
Although bright/dark transition behavior is a feature favorable for super-resolution 
imaging, blinking does not fit into conventional super-resolution strategies. This is because 
the dark period is much shorter than the bright period, and most QDs within subdiffraction 
distances are in bright states and emit fluorescence spectra that spatially overlap with each 
other. Researchers have investigated engineering of blinking behavior, yet most of this 
research is aimed at eliminating the dark period [33]. 
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In the recent decade, researchers have been trying to apply QDs in super-resolution 
imaging. Lidke et al. first attempted to use QD blinking and localize individual QD when 
all the adjacent QDs were in the “off” states [34]. However, this method could not 
distinguish a densely labeled area, because the chances of all the QDs within diffraction 
limit would blink off was very small. Dertinger et al. developed SOFI (super-resolution 
optical fluctuation imaging) algorithm to overcome the diffraction barrier [35, 36]. SOFI 
tracks the brightness fluctuation (mainly caused by QD blinking) of individual pixels over 
a number of frames, and applies high order correlation functions on each pixel, and the 
final image represents the degree of correlation rather than fluorescence. Wang et al. 
proposed a different approach named QDB3, and this approach localizes QD position by 
analyzing the differences between adjacent frames caused by QD on/off switching [37]. 
Compared with a single molecule localization strategy, SOFI does not impose a 
high requirement for SNR [38]. Nonetheless, some researchers argue that SOFI does not 
qualify as a super-resolution technique, because it cannot resolve densely labeled QDs 
within diffraction distances, which is a result of the short duration of dark states compared 
with that of bright states [29]. 
 
1.1.4 Perspectives 
 Despite all the efforts described above, QDs application in super-resolution 
imaging is still limited. For STED based imaging, Mn-doped QDs are not as bright as 
conventional CdSe based QDs because of the long exciton relaxing time in the dopant 
energy levels, brighter switchable QDs are required to increase SNR, especially for deep 
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tissue imaging. Moreover, since ~ M/cm2 scale laser intensity is required for modulation, 
extraordinary QD photostability will be a desirable feature. Therefore, we developed a 
surface coating method that can increase the stability and individual particle (assembly) 
brightness. 
 For STORM based imaging, the blueing method deliberately destroys QD surface, 
not only wasted the extraordinary brightness and stability of QD, but also raise concern 
whether the acquired images can represent the real mapping of biomolecules. QDs with 
improved blinking statistics (i.e., high on/off contrast, higher off population than on 
population) are still desired for STORM imaging. For SOFI and QDB3 that do not 
necessarily require a very high on/off contrast, these are still preferred features because of 
the increased SNR, which can improve the resolution and enables their application in deep 
tissue imaging. Our research proposed a novel way to alter QD blinking behavior, with the 
help of photo-responsive molecules and reversible quenching mechanism. 
 
1.4 Dissertation overview 
This dissertation is divided into 7 chapters. Chapter 2 discusses the general 
considerations for QD design, synthesis, and surface modification. Chapter 3 reviews QDs 
with multiple functionalities, including photo-responsive QDs, magnetic QDs, QD 
aptamer- and molecular beacons. Chapter 4 describes our efforts to improve the optical 
properties of current Mn-doped QDs. We first synthesized Mn-doped ZnSe QDs in organic 
phase, and transferred them into aqueous phase by micelle encapsulation, which improved 
their photo-stability and individual particle (assembly) brightness. We also investigated 
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our coating template with conventional CdSe/ZnS QDs, and obtained similar results. In 
Chapter 5, we further evaluate the effects of the micelle coating on QD cytotoxicity, which 
is a concern for QD in vivo imaging in general. We confirmed that the thick polymer 
micelle coating can significantly reduce QD toxicity. Chapter 6 summarized our design to 
enhance QD blinking statistics by building photo-switchable QDs based on azobenzene 
DNA molecules and reversible FRET, potentially applicable for STORM imaging. This 
chapter also includes work with gold nanoparticles and DNA origami, utilizing the same 
concept of azobenzene DNA modulation. Chapter 7 summarizes this research, and makes 
recommendations for future work.  
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Chapter 2: Quantum Dots synthesis and surface modification 
2.1 QD synthesis 
2.1.1 Synthesis overview 
QD synthesis in a nutshell is controlled crystallization. Generally speaking, it 
involves the formation of monomers, nucleation, and nanocrystal growth. In the seminal 
phase of QD research, they were synthesized by mixing salts containing the desired cations 
and anions (e.g., Cd2+ and S2- for CdS QDs) in aqueous solution, preferably with the help 
of surfactant (coordination ligands) to prevent nanoparticle aggregation into bulk 
precipitate [39]. However, this method generated QDs with poor quality and very little 
fluorescence. 
Murray’s group developed a QD synthesis procedure using thermal decomposition 
of organometallic precursors in hydrophobic solvents for CdS, CdSe, and CdTe QDs [40]. 
Dimethylcadmium was used as the precursor cadmium source, and tri-n-octylphosphine 
oxide (TOPO) was used as high boiling point solvent, as well as the coordination ligand. 
Dimethylcadmium is first mixed with TOPO, and the anion source was prepared in the 
form of TOPSe (taking CdSe as an example) in a different vessel, which was then injected 
into the first vessel at elevated temperature.  
This procedure involved highly dangerous chemicals, and could only produce QDs 
with ~ 10% quantum yield, but the approach of thermal decomposition of an 
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organometallic precursor has become a standard in the research community. Over the last 
two decades, researchers have developed “greener” chemistry routes for this reaction. For 
example, cadmium oxide was used to replace highly toxic and explosive dimethylcadmium 
as the precursor [41], and the combination of 1-octadecene [42] or paraffin liquids [43] and 
oleic acid was used to replace pyrophoric phosphine chemicals. 
 
2.1.2 Control of size distribution 
The control of size and size distribution is critical to QD optical properties. For a 
given material, the band gap energy, and therefore the emission wavelength, is dependent 
on quantum confinement, which is primarily determined by the size of the nanocrystal. 
Also the sharpness of the emission peak depends on the monodispersity of the nanocrystal 
size distribution. 
Peng et al., proposed the “focusing” theory to achieve a narrow distribution of 
particle size [44]. Assuming nanocrystal growth has diffusion as its rate limiting step, and 
the monomer concentration remains constant over short periods of time, then the growth 
rate of a particle at radius r is described as the following equation (derived from Gibbs-
Thomson equation): 
𝑑𝑟
𝑑𝑡
= 𝐾(
1
𝑟
+
1
𝛿
)(
1
𝑟∗
−
1
𝑟
)  Equation 1 
in which K is a diffusion related constant, ϭ is the thickness of diffusion layer, and r* is the 
critical radius corresponding to nanocrystals with zero growth rate. Particles larger than r* 
will grow at the expense of those smaller than r*, and thus the particle size distribution will 
be broadened. This phenomenon is referred to as Ostwald Ripening, or defocusing. On the 
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other hand, if all the particles have sizes larger than r*, then the relatively smaller ones will 
grow faster than the larger ones, and therefore yield a narrower or “focused” size 
distribution. Multiple injections of monomer (or precursor) are performed to compensate 
for the monomers consumed during nanocrystal growth, so that r* remains in a region that 
is smaller than most of the nanocrystals in the solution. 
Although focusing is the prevailing approach to achieve a narrow distribution, 
another mechanism of “self-focusing” has been proposed [45]. Unlike the focusing theory 
for which the number of nanocrystals remains unchanged, in the process of self-focusing, 
large nanocrystals grow at the expense of small molecules through interparticle interaction, 
rather than the particle-solution interaction. 
 
2.1.3 Core/shell quantum dots 
As synthesized cadmium chalcogenide QDs (i.e., CdS, CdSe, and CdTe) usually 
have a low quantum yield, and most of the fluorescence is lost during water-solubilization. 
The major reason for this is that surface traps, either formed because of the defects of the 
nanocrystal (daggling bonds) or produced by surface ligands, produce nonradiative 
pathways to dissipate the energy of the exciton, and quench QD fluorescence. 
This problem was mitigated by passivating the QD cores with an additional 
insulating layer to form a core/shell structured QD (i.e., CdSe/ZnS) [46, 47]. The insulation 
layer separates the exciton in the core from the surface charges to reduce non-radiative 
pathways. The quantum yield increased significantly from 10% to about 50%, and 
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remained stable during the ligand exchange from TOPO to pyridine, and the loss of 
fluorescence during phase transfer was mitigated. 
The CdSe/ZnS type of core/shell structure is usually referred to as a type I QD, and 
for type I QDs, the shell (ZnS) has a lower energy valence band (VB) and a higher energy 
conduction band (CB), so that the exciton is thermodynamically favorable to reside in the 
core. Type II QDs have a shell with a lower VB band, but also a lower CB band. Therefore, 
the positively charged hole is more likely to reside in the core, but the electron may drift 
to the lower energy CB band of the shell. This generally causes a red shift since the 
effective band gap is lower. Although type II QDs can protect excitons from surface hole 
traps, they are generally unstable and have a low quantum yield, because the electrons 
reside in the shell [17, 48]. 
One major factor that limits the quality of CdSe/ZnS QDs is that there is a large 
lattice mismatch (11%) between CdSe and ZnS crystals, which indicates that growing a 
thick layer of ZnS shell to protect the exciton may actually generate surface defects 
resulting from this mismatch. In contrast, a CdS shell only has a 3.6% mismatch to CdSe. 
One approach to synthesize defect free core/shell QDs is to use “alloyed” composition, 
either across the whole nanocrystal, or applied only on the shell and the interface between 
the core and the shell. Among types of QD compositions, CdSe QDs with graded CdS/ZnS 
shells have been shown to approach nearly unity quantum yields [19]. In addition, for 
alloyed QDs, one can alter the composition (i.e., Cd:Zn ratio and Se:S ratio) to change the 
band gap energy, so it is possible to produce multi-color QDs with a uniform size [49]. 
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An example of a state of the art of core/shell QDs is the “giant” QD [50]. This type 
of QDs has thick shells, up to 20 monolayers, in contrast with conventional CdSe/ZnS QDs 
that only have a few monolayers of ZnS. To synthesize giant QDs, the techniques of SILAR 
(successive ionic layer adsorption and reaction) must be applied [51], in which cations and 
anions are alternatively added to the solution (instead of simultaneously) so that no nuclei 
of shell material are formed during the growth phase. Giant QDs can be tailored to suppress 
blinking behavior [50, 52], which facilitates 3D molecular tracking (distinction between 
out of focus and blinking off QDs) [53]. Also, because of the thick protection layer, these 
QDs show great stability and are insensitive to ligand exchange. 
 
2.1.4 Cadmium free quantum dots 
The intrinsic toxicity of cadmium based QDs has raised serious concerns for its 
application in human health related applications. Cadmium free QDs have been studied, 
yet most of them do not possess extraordinary optical properties. For example, zinc based 
QDs [54] (ZnS and ZnSe core) have large band gap energy, and their emission spectra are 
usually limited to the near UV to blue range. Indium based QDs (InAs and InP) [55-57] 
are harder to synthesize and are less stable compared to II-IV types of QDs. Other QDs 
involving lead [58] have issues with stability and limited spectra range too, alongside the 
fact that lead is also a type of toxic heavy metal. 
One interesting type of QDs developed to address these issues is the doped QDs. 
Dopant ions (i.e., Mn, Cu) [59-61] are incorporated in the native nanocrystal, and reside 
either in the core or in the shell. The fluorescence mechanism of doped QDs is different 
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from the conventional QDs in that the exciton generated upon excitation first transfers the 
energy to the sub energy levels produced by the dopant, and then the exciton recombines 
and releases the energy in the form of a photon. The emission band gap is primarily 
determined by the type of the dopant, and it can only be tuned in a relatively small range. 
Also, the excitation spectra is mainly dependent on the native nanocrystal (i.g., ZnSe), and 
doped QDs usually need to be excited at relatively shorter wavelengths. Another drawback 
of doped QDs is that their exciton half lifetime is high (micro to millisecond), and therefore, 
individually, they are not as bright as conventional QDs [62]. 
Ternary and quaternary metal chalcogenides are another type of promising QDs 
[63, 64]. In contrast to conventional QDs that use II-IV elements, elements from group I 
(Au, Cu) and group III (Ga, In) are combined in replacement of group II elements, and 
form a ternary system. On the basis of the ternary system, if group III elements are further 
replaced by group II elements and group IV elements (Sn), it forms a quaternary system. 
Unlike doped QDs whose direct band gap is usually in the visible or even UV range, ternary 
and quaternary have low band energy, and they are good candidates for imaging in the NIR 
range, both for photovoltaics devices and imaging applications. The synthesis procedure 
for these QDs are generally more sophisticated than conventional QDs, but >50% quantum 
yield has been achieved. 
 
2.2 Surface modification 
QDs are usually synthesized in hydrophobic solvents, and require phase transfer to 
be used in biological systems. There are generally two approaches of water-solubilization: 
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ligand exchange and encapsulation. Afterwards, these QDs are functionalized with 
biomolecules (i.e., protein, DNA) for further application. 
 
2.2.1 Ligand exchange 
2.2.1.1 Monodentate thiol ligands 
In 1998, Chan et al., first developed the ligand exchange method to transfer 
CdSe/ZnS hydrophobic QDs to aqueous solution [65]. The ligand mercaptoacetic acid 
(MAA) contains a thiol group that can bind to the QD crystal lattice, and a carboxylate 
group to enhance water solubility. Purified QDs were dispersed in an organic chloroform 
phase, and MAA was added to the solution, followed by extraction with PBS buffer to 
transfer QDs from the chloroform phase to the aqueous phase. 
However, for most QDs, the products after direct ligand exchange are quite 
unstable, and suffer from significant loss of fluorescence. Similar ligands with various 
alkyl chains lengths were developed and used for ligand exchange, including but not 
limited to mercaptopropionic acid (MPA) and mercaptoundecanoic acid (MUA) [66]. In 
general, a longer alkyl chain mitigates this problem, but even in the most well optimized 
system with MUA ligands, losing quantum yield and aggregation seemed unavoidable. 
Although in recent years people have improved QD synthesis and made robust QDs that 
can withstand the ligand exchange procedure without losing fluorescence, this method is 
generally avoided. 
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2.2.1.2 Multidentate ligands 
One major problem with ligand exchange is that the binding affinity between sulfur 
and zinc is relatively weak (i.e., Zn-S bond is ~ half of the strength of Au-S bond). 
Therefore, the ligand can easily dissociate from QD surface, especially in lower pH where 
the thiolate groups are more likely to be protonated. To solve this problem, multidentate 
ligands were developed. For example, Mattoussi et al., developed dihydrolipoic acid 
(DHLA) ligands, which have two thiol groups as binding sites [67]. These ligands offered 
substantial increases in QD stability. Followed by this research, more DHLA ligand 
derivatives were designed. One approach is to conjugate DHLA ligands with poly(ethylene 
glycol) (PEG), which offers an additional layer to protect the binding site and the QD 
surface in general, as well as to reduce non-specific binding of QDs in biological systems 
[68, 69]. In addition, bi-dentate ligands were extended to tetra-dentate ligands by 
combining two DHLAs with one PEG chain [70], and even for multi-dentate ligands with 
multiple DHLA moieties assembled in one polymer backbone [71]. This approach yielded 
QDs stable in solution with pH from 2-14, and in the presence of 2M NaCl. 
Multidentate ligands have been proven successful, and the ligands are not limited 
to DHLA based molecules. For example, Peng’s group developed bi-dentate carboxylate-
anchored dendron ligands [72], Nie’s group used thiol and amine mixed polymers as the 
ligand backbone [73], Cai’s group produced multidentate−imidazole polymer ligands [74], 
and Weiss’s group used polypeptide ligands to bind to the QD surface [75]. All of these 
approaches generated QDs with good colloidal stability and decent quantum yield. 
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2.2.1.3 Compact quantum dots 
One of the advantages of ligand exchange over encapsulation approaches is that the 
initial hydrophobic ligands are replaced with new ligands, so that the formation of compact 
QDs (with small hydrodynamic diameter) is possible. This feature is particularly important 
when studying biological systems, especially in molecular tracking, since the molecule of 
interest is usually in the scale of a few nanometers (i.e., protein), and a large QD “probe” 
may interfere with the molecules being tracked. Also, for direct application in human body, 
small nanoparticles might allow them to be cleared through the kidneys, which lowers their 
potential toxicity. 
Although monodentate mercapto-acid ligands only add ~ 1 nm thickness to the QD 
surface, they always induce QD aggregation, and are not considered to generate compact 
QDs. Yet when they are conjugated with protection polymer layers to prevent aggregation, 
the hydrodynamic diameter usually increases to ~ 20 nm, even for QDs with cores less than 
5 nm. 
Bawendi’s group synthesized cysteine-coated CdSe/CdS-ZnS QDs that take 
advantage of the zwitterionic nature of the ligands, and formed QDs with a hydrodynamic 
diameters as small as 5.9 nm [76]. However, this type of QD still inherits the instability 
problem of monodentate ligands, and is only stable for 24 hours. Nienhaus’s group used 
zwitterionic D-penicillamine for compact QD synthesis and demonstrated better stability 
against aggregation and oxidation [77]. 
In recent years, researchers have proposed a “loops−trains−tails” type of ligand 
binding mechanism for polymer coated compact QDs [73]. In contrast with the “brush like” 
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binding forms for monodentate polymers that have one site bind to QD surface and the rest 
of the polymer chain daggling around, this mechanism usually requires polymers with 
binding sites at each repeating unit, so that the polymer can wrap closely around QD 
surface. In fact, most of the newly developed multidentate ligands apply this strategy [71, 
73-75]. 
 
2.2.2 Encapsulation 
QDs usually preserve their optical properties best with their initial ligands. 
Although the ligand exchange method is convenient, the new ligands usually reduce QD 
fluorescence to some extent. Encapsulation methods keep the initial hydrophobic ligands, 
and add additional amphiphilic molecules (i.e., lipid-PEG, block copolymer) whose 
hydrophobic part entangles with QD ligands, whereas and the hydrophilic part promotes 
water solubility. 
The first successful encapsulation method was invented by Dubertret et al., in 2002 
[78]. They first mixed QDs and phospholipids in chloroform, and allowed the solvent to 
evaporate, and then added hot water to dissolve the thin film to form micelles. This method 
was referred to as film hydration, and was used by various groups for QD encapsulation 
[23, 79]. Although this method was designed to encapsulate individual QD per micelle, in 
practice a significant fraction of empty micelles and aggregates could form. This problem 
can be solved by a recently developed “dual solvent exchange” method [80]. QDs and 
phospholipids were first mixed in chloroform, and DMSO was added to the mixture before 
the complete removal of chloroform. At this stage, QDs and phospholipids formed a semi-
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stable micelle structure. Water was slowly added to the mixture, and DMSO was removed 
by centrifugal filtration, and QD-micelles with good polydispersity were formed. 
Besides phospholipids, amphiphilic block copolymers are also used for micelle 
formation. For example Wu et al., developed octylamine-modified polyacrylic acid 
polymers for QD encapsulation [81, 82], Nie’s group used triblock polymer with 
hydrophobic polybutylacrylate and polyethylacrylate segments and a hydrophilic segment 
of polymethacrylic acid that had a hydrophobic hydrocarbon side chain.[83] Both of these 
micelles were formed using the film hydration method. Yu et al., applied poly(maleic 
anhydride-alt-1-octadecene) - PEG block copolymer, and used a slightly different 
encapsulation method: the amphiphilic polymer was first mixed with chloroform 
overnight, and the aqueous solution was added to the mixture before slow evaporation of 
the chloroform [84]. 
Our group has used polystyrene-ethylene oxide (PS-PEO) block co-polymers for 
micelle encapsulation of multiple nanoparticles in one assembly [85, 86]. We used a 
different mechanism for micelle formation: interfacial instability developed by Zhu et al., 
[87]. QDs and PS-PEO amphiphilic molecules were dissolved in chloroform and the 
organic mixture as added to an aqueous solution (containing polyvinyl alcohol) with strong 
agitation (high speed vortex or sonication) to disperse chloroform as small droplets in the 
aqueous solution. With the slow evaporation of chloroform, the droplets shank, the 
oil/water interface became unstable, and bigger droplets dissembled into smaller ones, until 
all chloroform was evaporated and micelle encapsulated QDs were formed. 
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2.2.3 Bioconjugation 
After ligand exchange or encapsulation for phase transfer, QDs usually need to be 
conjugated with functional molecules (i.e., antibody, peptide, DNA) to be used in 
biological applications [88]. The earliest method for conjugation was similar to ligand 
exchange: biomolecules (protein and peptide) containing or modified with thiol groups 
(DNA oligo) wer used so that they could bind to the QD surface directly [89, 90]. This 
method usually shares the same problem with monodentate ligands in that the linkage is 
quite unstable. However, it is possible to modify proteins with high affinity binding groups. 
For example, C-terminal pentahistidine sequence (5-HIS) modified protein can bind to the 
zinc ions on QD surface with high affinity [88]. 
Many of the hydrophilic parts of the ligands or the amphiphilic block copolymer 
used in other approaches involves carboxylate groups; EDC (3-dimethylaminpropyl 
carbodiimide) chemistry that can conjugate carboxylate groups with amine groups to form 
a stable amide bond has been well studied. NHS (N-Hydroxysuccinimide) or sulfo-NHS 
(N-hydroxysulfosuccinimide) is commonly used together with EDC to promote 
conjugation efficiency. However, in most cases, EDC chemistry has relatively low 
conjugation efficiency for nanoparticles, and the overuse of EDC may quench QD 
fluorescence and/or cause QD aggregation [67, 91]. 
Reagent free conjugation chemistry has offered a convenient way for tethering 
biomolecules. The earliest chemistry using this approach is the biotin-streptavidin antibody 
interaction, which has binding affinity similar to a covalent bond. However, streptavidin 
by itself is a large protein molecule, and this chemistry may greatly increase the 
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hydrodynamic diameter of the QDs, therefore it is unfavorable for most biological 
applications. Over the years, quite a few small binding moiety pairs have been developed 
[92], including but not limited to azide-alkyne cycloaddition (click chemistry), thiol-
maleimide, thiold-iodoacetate, amine-isothocyanate, and disulphide formation. These 
newer methods usually offer high conjugation efficiency, and ease of purification. 
Recently, a very interesting method for DNA conjugation was developed. Instead 
of conjugating DNA after the QD synthesis was finished, the QDs cores were first 
transferred to aqueous solution with ligand exchange, and multiple thiol group modified 
DNA oligos were embedded into QD lattice during ZnS shell growth [93]. This method 
produces QD-DNA conjugates with great stability, and is conceptually transferrable to 
other types of ligands/biomolecules. 
 
2.3 Conclusions 
The synthesis of QDs has achieved great progress over recent years. Near unity 
quantum yield and non-blinking QDs with emission colors that covers the whole visible 
spectra and NIR range can be produced. Cadmium free QDs, especially doped QDs, ternary 
and quaternary have shown great promise for biological applications, although at the 
current stage, these QDs cannot match the superb optical properties of cadmium 
chalcogenide QDs. 
As for phase transfer, ligand exchange and micelle encapsulation can produce 
relatively stable QDs with functional groups for biomolecule conjugation. Both of these 
approaches have their merits. Ligand exchange offers the possibility to produce the most 
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compact QDs with the “loops−trains−tails” strategy, but the micelle encapsulation method 
can better preserve QD optical properties, because the initial ligands remain intact. 
Therefore, the choice of phase transfer method depends on the specific application in 
question. 
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Chapter 3 Multifunctional Quantum Dots 
Section 3.2 is adapted from our published paper [94] with permission (Appendix 
9). 
Fluorescence microscopy provides real time tracking, non-invasive imaging, and 
can achieve high resolution, and has become one of the most useful tools in biological and 
biomedical studies. QDs, as superior fluorescent probes to molecular dyes and fluorescence 
proteins, have been used in bioimaging both at a cellular level [95] and at an animal level  
[83].  
Like most dyes, QDs need to be conjugated with antibodies to label a specific target, 
in contrast to some DNA binding dyes and gene encoded fluorescent proteins. But to fully 
exploit the advantages of QDs, it is beneficial to combine QDs with environmental stimuli 
responsive molecules/nanoparticles to introduce additional functionality. For example, pH 
sensitive QDs [96] may provide tools for imaging specific subcellular compartments, or 
serve as pH probes. Photo-switchable QDs can be used in super-resolution imaging, and 
may introduce new approaches for multiplexing. Specific molecule responsive QDs can be 
used as molecular beacons [97, 98]. 
Another promising combination is to produce magnetic QDs. For imaging purposes, 
magnetic particles are routinely used in MRI imaging, which lacks the resolution 
achievable by fluorescence imaging, but compensates with a comprehensive scan of the 
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whole tissue/body, whereas fluorescence alone can only penetrate tissues for a few 
millimeters. Therefore, magnetic QDs can provide both the big picture and detailed 
information at a local spot. In addition, these QDs can be manipulated with magnetic fields, 
which may be applied in multimodal imaging, molecular/cellular detection and separation, 
and theranostics. 
In this chapter, section 3.1 reviews a few of the most widely used photo-responsive 
molecules, as well as the construction of photo-switchable QDs, and summarizes their 
merits and flaws, which leads to a novel design of photo-switchable QD described in 
chapter 6. Section 3.2 reviews the synthesis strategies for magnetic QDs, whose dual-
functionality offers great potential in biological and biomedical research. In specific, the 
Mn-doped QDs mentioned in these strategies are further studied in chapter 4 and 5. 
 
3.1 Photo-responsive Quantum Dots 
3.1.1 Photo-responsive functional groups 
Light is generally considered a non-invasive stimulus for biological systems. 
Researchers have developed a variety of photo-responsive molecules that cleave or 
crosslink irreversibly upon photo-activation or switch conformation reversibly in response 
to light of different wavelength. Table 1 lists the chemical structures of some representative 
types of photo-responsive functional groups, which are frequently applied in light 
controllable biomaterials. It should be noted that there are various types of photo-
responsive molecules other than those listed in Table 1, and more comprehensive reviews 
on this subject can be found in reference see [99-101]. 
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Table 1: Chemical structures of most common photo-responsive molecules [99-101] 
 
Name Chemical structure Reversibility 
o-nitrobenzyl 
 
No 
coumarin-4-
ylmethyl 
 
No 
p-
hydroxyphenacyl 
 
No 
Azobenzene 
 
Yes 
 
To be continued in next page 
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Table 1 continued: 
Spiropyran/ 
Merocyanine 
 
Yes 
Diarylethene 
 
Yes 
 
 
3.1.1.1 Irreversible molecules 
Among all of the photo-responsive moieties, o-nitrobenzyl, coumarin-4-ylmethyl, 
p-hydroxyphenacyl and their derivatives are most commonly used as photocleavable 
molecules. These molecules were first introduced as photo-removable protection groups in 
organic synthesis [99], and are now widely-used in biological applications. For example, 
when these molecules are incorporated into hydrogels, one can manipulate the physical and 
chemical properties of these hydrogels by light; therefore, modulating the biological 
environment, protein activity, and even cell behavior [102-105]. Moreover, most 
biomolecules have functional groups such as amino, hydroxyl, carboxylate, and phosphate 
groups that are essential for their bioactivity. When these molecules are conjugated with 
photo-labile molecules, their bioactivities are “caged”, until modulation light is applied to 
cleave the photo-labile molecules and restore their functionality. Both small molecules (i.e., 
calcium, glutamate, and ATP) and larger biomolecules (i.e., nucleic acid, peptides, and 
N O NO2
R
N
R
O
NO2
Spiropyran Merocyanine
SS
R R
R R
SS
R R
R R
33 
 
proteins) have been modulated with this strategy [100]. Also, these photocleavable 
molecules can either be directly used as a photo-responsive protection/caging agent or be 
applied as a photo-labile linker. For example, functional proteins can be conjugated with 
an o-nitrobenzyl modified PEG protection layer, and their functionality is only active when 
the PEG layer is removed by the light [106].  
  
3.1.1.2 Reversible molecules 
Photo-switchable molecules have also been incorporated in biological systems to 
regulate nucleic acids hybridization, peptide conformation, and enzyme activities [107]. 
These photo-switches include molecules that have a C=C bond or N=N bond that 
undergoes trans-cis isomerization upon photo-modulation (e.g., azobenzenes, stilbenes, 
hemithioindigoes), and molecules that incorporate aromatic ring which can open reversibly 
(e.g., spiropyrans, diarylethenes, triphenefulgides). In particular, the isomers of 
spiropyrans molecules, or merocyanines, have a zwitterionic structure which increases the 
molecular polarity significantly. Limited by the scope of this dissertation, this chapter will 
only review one of the most widely used photo-switchable molecules, azobenzenes, which 
inspired the design of our photo-switchable QDs described in chapter 6. 
Azobenzenes have a trans-cis photoisomerization, and the energy required for trans 
to cis is higher than the reverse process. For trans to cis transition, light only provides 
enough energy to overcome the barrier to the activated state. At this state, the azobenzene 
molecule can either switch to the cis state or relax back to the trans state, therefore the 
transition from trans to cis never reach 100% efficiency. On the contrary, cis to trans 
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isomerization requires less energy, and can eventually achieve full conversion (Figure 4) 
[108], and cis state can gradually relax to trans state even in the absence of light, and the 
thermal stability is highly affected by the modifications on the benzene rings, and the half-
life of the cis state ranges from 0.7 seconds to 43 hours [109]. In addition, UV light is 
usually required for the trans to cis transition, which might impose potential harm on some 
delicate biological structures. To solve this problem, azobenzene derivatives (BF2 ‑
coordinated azo) that switch under visible light (450 nm/570 nm) have been developed, 
and have yet to be incorporated in biological systems [110]. 
 
 
Figure 4: Azobenzene photoisomerization energy diagram adapted from [108] 
 
Azobenzene molecules have many interesting applications. For example, they can 
be conjugated with peptides and proteins to controlled bioactivity [101], incorporated in a 
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microgel to enable light triggered swelling and degradation [111], or be used to create 
photo-switchable liposomes [112]. When these molecules are incorporated in a polymer 
backbone, the polymer can shrink/expand in response to light, and this process can transfer 
light energy into mechanical force [108]. However, despite the novelty of this 
“nanomachine”, there is only ~ 2.8 nm of change in length for an 88 nm polymer chain. 
 One of the most promising applications of azobenzene molecules is azobenzene 
modified DNA [113]. This concept was first developed by Asanuma et al. in 1999 [114] 
by modifying the azobenzene with a diol group, and directly inserting the azobenzene to 
the DNA backbone by forming a phosophodiester bond (Figure 5: Structure of azobenzene 
inserted DNA [114]). In the trans configuration, the inserted azobenzene produces minimal 
disturbance to ssDNA activity, so that it can still hybridize with its complimentary 
sequence, yet the cis configuration induces dehybridization. After this initial work, 
researchers have developed optimized methods for azobenzene insertion including the 
chirality of insertion, number of azobenzene in the sequence, positions of azobenzene etc., 
to ensure good thermal stability in the cis state and a larger melting temperature difference 
between the two conformations [115-117]. For biological applications, azobenzene DNA 
has been used to photo-regulate the DNA polymerization [118], RNA transcription [119], 
and RNA digestion [120]. Also, these molecules can be used to design photo-responsive 
nanomachines such as a DNA “nanowalker” [121]. 
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Figure 5: Structure of azobenzene inserted DNA [114] 
 
 In addition to changing the configuration of photo-responsive molecules to achieve 
reversible photo-regulation, another approach is to apply photo chemistry that can 
form/break a bond at different wavelengths. For example, the [2+2] cycloaddition reaction 
between cyanovinylcarbazole nucleoside and pyrimidine (thymine or cytosine base) can 
be initiated by 366 nm irradiation, and be reversed at 312 nm, and this mechanism can also 
be used to produce photo-switchable DNA.  It should be noted that this process only takes 
1 second for the forward reaction and 60 seconds for the reverse reaction, which is faster 
than azobenzene DNA based hybridization (~ minutes) [122]. 
 
3.1.2 Photo-switchable quantum dots 
Photo-responsive Mn-doped ZnSe QDs and blueing-based CdSe QDs were 
discussed in Chapter 1. Instead of engineering the band gap and energy levels of QDs, this 
section discusses a different approach for constructing photo-switchable QDs, reliant on a 
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quenching mechanism. This type of QDs contains two parts: 1) core/shell CdSe/ZnS QDs, 
2) molecular quenchers, and 3) an element to promote photo-modulation of the quenching 
efficiency.  
There are primarily two ways to quench QD fluorescence. The first quenching 
mechanism is fluorescence resonance energy transfer (FRET), which describes the energy 
transfer from an excited energy donor to a ground-state energy acceptor through dipole-
dipole coupling [123, 124]. In this case, the activated QD (with exciton) is regarded as the 
energy donor, and fluorescent dyes are usually used as energy acceptor (quenchers). The 
quenching efficiency is determined by the distance between the QD and the quencher and 
the spectral overlap between these two compounds. To achieve photo-regulation of FRET 
efficiency, the spectral overlap is usually exploited. As discussed above, photo-switchable 
molecules change configuration in response to light. Since configuration change is 
accompanied by a change of absorbance spectra, photo-regulated changes in molecular 
structure can indirectly change the spectral overlap and the quenching efficiency.  
For the choice of quencher molecules, Medintz et al. used spiropyan/merocyraine 
incorporated fluorescent proteins and achieved ~ 60% modulation depth [125]. Zhu et al. 
conjugated the spiropyan/merocyraine pair directly to the QD shell through a thiol bond to 
enhance the quenching efficiency, and showed almost complete quenching (at 588 nm), 
but because of an instability issue, after 4 cycles only ~half of the fluorescence remained 
in the bright state [126]. Jares-Erijman et al. used diarylethene derivative groups as 
quenchers, but only achieved 34% reversible quenching [127]. Although the quenching 
efficiency is lower, diarylethenes can undergo more than 104 isomerization cycles without 
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fatigue, which is significantly better than the spiropyan/merocyraine pair. Díaz et al. also 
used diarylethene derivatives as quenchers with comparable modulation depth (35-40%) 
[128], and the same group later improved the efficiencyto higher than 50%, and also 
achieved “dual color” emission by incorporating Alexa 647 in the polymer shell [129, 130]. 
The second quenching mechanism is charge transfer. After the exciton is formed, 
if the QD surface contains a charge acceptor, the high energy electron (or hole) can migrate 
and combine with the charge acceptor, and dissipate the energy in a non-radiative manner. 
Impellizzeri et al. conjugated QDs with o-nitrobenzyl, an electron acceptor as well as a 
photocleavable molecule. After UV irradiation, o-nitrobenzyl groups left the QD surface 
and QD fluorescence resumed. This process is irreversible, and the modulation depth was 
about 44% (80% enhancement in fluorescence after activation) [131]. 
 Besides insufficient quenching efficiency, these methods all share the same 
property that limits their application in STORM imaging. Since single molecules do not 
have a high quenching efficiency for QDs, multiple quenchers are needed to achieve a 
sufficient modulation depth. Although at the single molecular level, the isomerization 
process is stochastic, when multiple quenchers are present, the stochastic property is 
averaged out. Therefore during imaging, all the QDs in a certain area are either in bright 
state or in dark state, but STORM requires most of the fluorophores to be switched off with 
a small subset of fluorophores remaining fluorescent for localization.  
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3.2 Magnetic quantum dots 
3.2.1 Synthesis of magnetic quantum dots 
The synthesis of fluorescent-magnetic nanoparticles has been well documented 
[132]. From the perspective of composition, either super-paramagnetic nanoparticles such 
as iron oxide or paramagnetic components including Mn2+ and Gd3+ ions are coupled with 
fluorescent QDs. These nanoparticles may contain different morphologies, yet most 
synthesis procedures can be classified into four groups: high temperature decomposition, 
doping, coupling, and encapsulation. In the first approach, one type of nanocrystals is first 
formed, and the other species are added to the solution, which grow upon or next to the 
first nanocrystals. In the second approach, transition metals are doped in the nanocrystal to 
provide fluorescence and magnetic properties. In the third approach, magnetic 
nanoparticles and fluorescent species are synthesized separately and are conjugated to each 
other by additional linkers or electrostatic forces. In the fourth approach, magnetic 
components and fluorescent components are encapsulated together in a matrix. 
 
3.2.1.1 High temperature decomposition 
The high temperature decomposition method is similar to the CdSe/ZnS core/shell 
QD synthesis described in Chapter 2. A core material is synthesized first (e.g., Fe3O4, Fe2O3, 
FePt, FeP, Co), which then serves as a template for growth of the second material (e.g., 
CdS, CdSe, CdTe). Two types of fluorescent-magnetic nanoparticles can be created using 
this approach. The first is a core/shell heterodimer consisting of two distinct materials [133, 
134]. The second type initiates as a heterodimer, but then interfacial instabilities (e.g. lattice 
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mismatch or strain) result in the migration of constituent atoms, leading to the formation 
of dumbbell-shaped particles with two distinct domains [135-137] (Figure 6A). The 
ultimate shape of the nanocomposites formed is mainly determined by crystal lattice 
mismatch and reaction conditions (e.g., temperature, reactant ratios). 
 
 
Figure 6: Synthesis of magnetic fluorescent nanoparticles. A) High temperature 
decomposition (B) Doping (C) Crosslinking 
 
A major shortcoming of this approach is the inability to optimize properties of the 
constituent materials. The initial nanocrystal can be synthesized under optimal conditions; 
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however, in the synthesis of the subsequent material, the initial crystal can be subjected to 
a range of temperature changes that affect its structure. Also, it is possible for unintended 
interfacial doping to occur between the two materials [135]. These difficulties, combined 
with interactions between the two material domains that result from simple proximity, can 
lead to reduced brightness and/or magnetism. Loss of fluorescence most likely results from 
interference of the metallic domain (i.e., nonradioactive quenching) [133] and from poor 
quality of the fluorescent nanocrystal. For example, when Fe3O4/CdSe (core/shell structure) 
nanocrystals were coated with ZnS, the quantum yield increased from 2–3 to 10–15% [134], 
indicating a role of defects in the crystal surface. However, these values are far below the 
~50% or higher that can be achieved in standard core/shell QD materials. Losses of the 
magnetic property probably result from disorder in the magnetic crystal structure that 
occurs because of sub-optimal synthesis conditions, doping, or interfacial instabilities in 
the two crystal lattices [135]. 
 
3.2.1.2 Doping 
The second major approach to creating fluorescent-magnetic nanostructures is to 
add transition elements into the nanocrystal lattice as dopants. In contrast with the first 
method in which nanocomposites exhibit multifunctionality resulting from two distinct 
material domains, in doped materials, both fluorescence and magnetic properties are 
produced by the energy states introduced by dopant ions. One of the best-studied examples 
of these materials is manganese-doped nanoparticles, which have been examined primarily 
for photoluminescence imaging, magnetic spintronics, and more recently magnetic 
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resonance imaging (MRI) [138, 139] (Figure 6B). Mn2+ can be doped in both II–VI and 
III–V nanocrystals, either in the core or the shell [26, 60, 138-144]. The position of Mn2+ 
determines the optical and magnetic properties of the material. Doped materials offer 
advantages versus materials synthesized via high temperature precursor decomposition in 
that interactions between the two material types are desired and drive the 
fluorescent/magnetic properties. However, doped materials are limited by the range of 
available dopants and the difficulty in synthesizing doped structures. 
 
3.2.1.3 Crosslinking 
To optimize the properties of constituent materials, researchers have pursued 
methods that permit separate synthesis of nanoparticles, which are later combined via 
another method (e.g., crosslinking, encapsulation; Figure 6C [145]). Fluorescent-magnetic 
nanoparticles formed via crosslinking primarily employ superparamagnetic iron oxide 
nanoparticles (SPIONs) for the magnetic material. Coupling ligands typically contain 
functional groups that bind both materials, such as thiol, carboxyl, or siloxane groups [96, 
145]; however, proteins have also been used to mediate these interactions [146]. 
Alternatively, some crosslinking strategies employ no chemical linker, instead using 
charge attraction to mediate interactions. For example, positively charged Fe3O4 
nanoparticles and negatively-charged carboxy-CdTe QDs were bound together via static 
electric forces [147]. This model has the advantage that the carboxyl groups on the QDs 
surface formed chelating, bidentate acetates with Fe ions, further strengthening the binding. 
Crosslinking avoids many of the limitations of sequential synthesis or doping approaches; 
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however, the structures formed can be bulky and the stability of the binding ligands and 
crosslinkers can vary in different environmental conditions [96]. 
 
3.2.1.4 Encapsulation 
 Encapsulation-based fabrication methods incorporate pre-formed magnetic 
nanoparticles and QDs into a matrix [79, 85, 148-150]. Specific encapsulation methods 
were described in Chapter 2, section 2.2.2. Encapsulation methods avoid the inherent 
problems of controlled crystallization and doping, because the synthesis of fluorescent and 
magnetic nanoparticles is performed separately. In addition, no coupling agents are needed, 
eliminating the requirement for stable nanoparticle-ligand-linker interactions. 
 
3.2.2 Applications of magnetic quantum dots 
The most important application of magnetic QDs is multimodal imaging. 
Fluorescence microscopy and magnetic resonance imaging (MRI) are two popular 
techniques used in biomedical research. In general, fluorescence microscopy can achieve 
better resolution, but the tissue penetration depth is usually limited to a few millimeters. 
On the other hand, with the help of paramagnetic or superparamagnetic component as a 
contrast agent, MRI has the capacity to examine the body comprehensively, yet its spatial 
resolution cannot match that of fluorescence microscopy. The coupling between QDs and 
magnetic components can combine these two techniques to achieve multimodal imaging. 
So far, both paramagnetic components (i.e., Mn2+, Gd3+) [138, 139, 151-153] and super-
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paramagnetic components (i.e., iron oxide nanoparticles) [79, 154, 155] have been 
incorporated with QDs that showed great potential for biological studies. 
Magnetic QDs can also be used in molecular/cellular detection and separation. 
These QDs are tethered with antibody or ssDNA sequence complimentary to the target 
DNA/RNA to bind with molecules of interest or specific cells. With the help of an external 
magnetic field, these molecules/cells can then be separated and observed or examined 
without interference from similar molecules/cells [156-160]. Compared with bulk 
measurement, magnetic QD-based assays can detect DNA/RNA in as low as femtomolar 
(10-15) concentrations and distinguish DNA sequences with single base pair mismatches 
[159]. 
Nanoparticles have many advantages as drug delivery vehicles (controlled release, 
targeting), and when combined with imaging agents, offer the potential for simultaneous 
treatment and diagnosis, i.e., theranositics. However, despite this exciting concept and a 
few pioneering attempts [161-163], many hurdles need to be overcome before these 
nanoparticles can be used clinically. The toxicity of QDs is a significant issue, which has 
prompted a great deal of interest in the development of alternative fluorescent probes and 
non-toxic QDs (see more in Chapter 2, section 2.1.4 and chapter 5). Similarly, the efficacy 
of passive versus active targeting approaches in diseases such as cancer is debatable [164]. 
Passive delivery is not uniform; however, active delivery, particularly via antibody-
conjugated probes can lead to enhanced uptake by the reticuloendothelial system (RES). 
Newer targeting probes, such as aptamers, are emerging that may limit this interaction, 
improving targeted delivery [165, 166]. Further, earlier assumptions regarding nanoparticle 
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disposition in the body are now being questioned [167], and more detailed study is required 
to comprehend the fate of nanoparticles after accumulation in tumor tissue. 
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Chapter 4: Micelle-templated Mn-doped ZnSe quantum dots 
synthesis and characterization 
 This chapter is adapted from our published paper [168], except for the introduction.  
In Chapter 1-3, we have reviewed the importance of Mn-doped QDs. First, these 
QDs are photo-switchable, and have been used in super-resolution imaging (STED), 
despite the high modulation power and their deterministic on/off switching nature. Second, 
Mn2+ are paramagnetic components, and Mn-doped QDs have been used as an MRI 
contrast agent. Third, these QDs are free of heavy metals, potentially less toxic than 
cadmium based QDs, and may have a better applicability for in vivo applications. 
 Previously our group has developed the PS-PEO (polystyrene-polyethylene oxide) 
micelle template to produce color-alternating QDs and magnetic QDs (MagDots) [85, 86]. 
Particularly, these MagDots have been successfully used in molecular/cellular detection 
and separation. Here, we combine the merits of Mn-doped QDs and the PS-PEO platform 
with the intention of enhancing their optical properties and photostability in comparison to 
MPA (mercaptopropionic acid) ligand-coated counterparts. In addition, to evaluate the 
transferability of the micelle template, we also prepared commercial QD-micelle 
assemblies, and compared these with mercaptopropionic acid (MPA) ligand or polymer-
coated QDs. 
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4.1 Materials and methods 
4.1.1 Materials 
Zinc stearate (12.5-14%, ZnO), selenium powder (99.999%, ~200 mesh), 
tetramethylammonium hydroxide pentahydrate (TMAH, 25% w/w in methanol), 
manganese chloride (MnCl2, 97%), and octadecylamine (ODA, 98%) were purchased from 
Alfa Aesar. Stearic acid (SA, ≥98.5%), 1-octadecene (ODE, ≥95.0%), 3-
Mercaptopropionic acid (MPA, ≥99%), and tributyl phosphine (TBP, 97%), acetone 
(≥99.9%), and Poly (vinyl alcohol) (13,000-23,000 Dalton, 87-89% hydrolyzed, PVA) 
were purchased from Sigma-Aldrich. Chloroform was purchased from Mallinchrodt 
Chemicals. Poly(styrene-b-ethylene glycol) (PS-PEG) with a molecular weight of 3800-b-
6500 (Dalton) was purchased from Polymer Source. Organic ZnS-CdSe QDs (λem = 605 
nm) in decane and carboxy-ZnS-CdSe QDs (λem = 605 nm) in pH 9 borate buffer were 
purchased from Invitrogen. 
 
4.1.2 Preparation of the Mn-ZnSe QDs  
Mn-doped ZnSe QDs were synthesized according to the method of Peng [169, 170]. 
 
4.1.2.1 Synthesis of MnSt2 precursor 
Briefly, 1.42 g of SA was dissolved in 10 mL of methanol in a 100 mL three-neck 
flask and heated to 50-60 °C until the solution became clear. The solution was then allowed 
to cool to room temperature. Next, TMAH solution was prepared by adding 2.3 mL of 
TMAH stock solution to 1.5 mL of methanol. This solution was added dropwise to the SA 
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solution until the white precipitate disappeared. Then, 0.315 g of MnCl2 was dissolved in 
3.15 mL of methanol and added dropwise via an addition funnel into the above solution 
under vigorous stirring, causing a white precipitate to form and flocculate. This precipitate 
was collected, washed with methanol six times, and dried under vacuum.  
 
4.1.2.2 Synthesis of Mn-ZnSe QDs 
In a typical experiment, TBP-Se stock solution was prepared inside a glove box by 
adding 0.63 g of Se to 2.7 mL of TBP. One and a half milliliters of this solution was mixed 
with 1.3 g of ODA in a 25 mL flask, removed from the glove box, immediately protected 
with Ar, and heated to about 70˚C under Ar. Also, ZnSt2 stock solution was prepared by 
adding 2.5 g ZnSt2, 0.5 g stearic acid, and 12 mL ODE to a 50 mL flask. The solution was 
maintained at ~150 ˚C and degassed with argon. 
Then, 25 mL of ODE and 0.1g of MnSt2 were loaded into a 100 mL three-neck 
flask, heated to 110°C, and bubbled under argon for 20 minutes. The temperature was 
increased to 280°C and the argon source changed from bubbling to flow. Once the reaction 
temperature reached 280°C, 3 mL of TBP-Se stock solution was swiftly injected. After five 
minutes, the temperature was reduced to 260°C and held for 60 minutes. The temperature 
of the reaction was then increased to 290°C, 4 mL of the heated ZnSt2 stock solution was 
injected into the reaction solution, and 0.6 g ODA in 0.6 mL ODE was heated using a heat 
gun and injected into the reaction solution. After 15 minutes, the remainder of the ZnSt2 
stock solution was injected into the reaction flask in 3 mL intervals every 15 min for a total 
of three injections followed by ODE/ODA injection. The reaction solution was next cooled 
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to room temperature, and the nanocrystals were purified using chloroform and acetone. 
Briefly, 1 mL of chloroform was added to 1 mL of reaction solution, and heated using a 
heat-gun until the solution became clear. Two milliliters of acetone was then added to the 
solution to precipitate the QDs. The nanocrystals were isolated by centrifugation at 4000 
rpm for 3 min and dispersed in 1 mL of chloroform for further use. This purification step 
was repeated three times.  
 
4.1.3 Synthesis of water-soluble QDs by ligand exchange 
Both water-soluble ZnS-CdSe and Mn-ZnSe QDs were produced from organic 
precursors in chloroform via ligand exchange with 3-mercaptopropionic acid (MPA). 
Organic ZnS-CdSe QDs in decane were first transferred to chloroform using a 
methanol/isopropanol mixture (75/25 in volume) to precipitate the QDs, which were then 
diluted to 0.1 µM for further use. Twenty microliters of MPA were added to 100 µL of 
QDs (either Zn-CdSe or Mn-ZnSe in chloroform), and after vortexing for 20 minutes, the 
flocculated MPA-capped QDs were isolated by centrifugation. QDs were washed once 
with chloroform, and then dispersed in 3 mL of water. NaHCO3 was then added to the 
solution until the QDs were completely dissolved.  
 
4.1.4 Synthesis of the QD-encapsulated micelles 
Micelles encapsulating QD nanoparticles were created using the interfacial 
instability process [171]. QDs and PS-PEG co-polymer amphiphile (i.e., 50 µL ZnS-CdSe 
QDs and 10 µL polymer; 200 µL Mn-ZnSe QDs and 20µL polymer) were mixed 
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thoroughly in a 1.5 mL centrifuge tube. This mixture was added to an aqueous solution of 
poly(vinyl alcohol) (800 µl, 5 mg/mL), which served as a surfactant. After vortexing for 3 
minutes, the emulsion formed was transferred to an open container (i.e., a 10 mL glass vial) 
to permit evaporation of the chloroform. The vial was rotated to spread emulsion droplets 
on the wall and to enhance the rapid evaporation of chloroform. The milky emulsion 
droplets became transparent after the removal of chloroform, indicating the formation of 
micelles containing QDs. 
 
4.1.5 Characterization of QDs and QD-micelles  
Transmission electron microscopy (TEM) observations were performed using an 
FEI Tecnai G2 Spirit TEM. To observe micelles, samples were negatively stained with 1% 
phosphotungstic acid (PTA) before observation. Absorption spectra were collected with a 
Thermo Electron Corporation Genesys 6 spectrophotometer. Fluorescence emission 
spectra were measured using a PTI QuantaMasterTM 40. Quantum yield was determined 
using commercial ZnS-CdSe QDs in decane (Invitrogen) with known quantum yield (80%) 
as a reference using a method adapted from Peng [169]. These particles have an 
overlapping emission peak with that of the Mn-ZnSe QDs and can be excited at the same 
wavelength. Dynamic fluorescence intensity was measured using an Olympus BX41 
microscope (100x oil immersion objective) equipped with a 100W mercury lamp (Chiu 
Technical Corporation). Fluorescence emission was filtered through a long-pass filter and 
collected by a Photometrics Evolve EMCCD camera. Fluorescence intensity measurements 
over time were analyzed using MetaMorph Basic software (Olympus). 
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4.1.6 Photo-oxidization and photo-modulation measurements 
To perform photo-oxidation and photo-modulation measurements, 15 µl of QD 
solution was dried on a cover slip, which was then mounted on a glass slide using 3-5 µl 
of glycerol or ultra-pure distilled water (18.2 MΩ·cm). If QDs on the slide were too dense 
for measurement, lower concentrations slides were attempted. Photo-oxidation 
measurements were performed on multiple QDs in a defined area (Figure 7), with 
representative data shown. Photo-oxidization data was acquired using an Olympus IX71 
inverted microscope with a 60x oil objective (Plan Apo N). The microscope is equipped 
with a Prior ProScan xy stage and a Prior NanoScanZ piezo stage for focusing. 
Fluorescence was imaged using an Andor EMCCD camera (DV887DCS-BV with 14bit 
ADC). Between the microscope and the CCD camera, additional optics were inserted 
including a deformable mirror (Mirao 52E, Imagine Optics) for PSF correction and two 
lenses for an extra 3x magnification so that the 16 micron CCD pixel size corresponds to 
89 nm at the sample. The sources of light used for the tests were a 405 nm LED (Thorlabs 
M405L2) and a 488 nm Laser (Spectra-Physics 488nm Cyan Laser System). The LED light 
was set to 119 µW for continuous exposure and the laser source was set to 20 mW. In the 
non-continuous tests, the sample was exposed to 100 ms of light exposure on each step. 
Each step of the test was repeated at a range of z levels to track the location of the QDs 
during movement. 
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Figure 7: A frame from the photo-oxidation of Mn-ZnSe doped QD micelles. 
 
To measure the modulation of Mn-ZnSe QDs, the QDs were excited with widefield 
excitation from the 405 nm LED and imaged on the Andor Camera as above. The excitation 
intensity was less than 1 W/cm2. To modulate the QDs, the slide was additionally excited 
with a focused spot from a 660 nm laser (100 mW, OBIS 660 LX, Coherent), which served 
as the modulation beam. The modulation spot was created by slightly under-filling the back 
aperture of the microscope objective and was focused onto the image plane. The spot 
diameter was 1.0 µm full width at half maximum. The intensity of the modulation beam at 
the sample could be varied up to 12.5MW/cm2. 
Data from these experiments was analyzed using ImageJ software. The software 
recognizes fluorescent spots (i.e., QDs) in each frame and can track QD movement to a 
new position. The mean value of emission intensity of each QD was measured; values are 
normalized to their initial intensity. For each test, measurements were performed on several 
QDs, and in cases demonstrating the same pattern, the series with highest intensity (hence 
the least noise) was chosen for comparison. 
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4.2 Results and Discussion 
4.2.1 QD Synthesis 
To compare the efficacy of micelle encapsulation to standard water-solubilization 
methods, ZnS-CdSe and Mn-ZnSe QDs were prepared using either ligand exchange or 
micelle encapsulation (Figure 8). In both cases, organic QDs were used as precursors. For 
the ligand exchange approach, the original organic layer (i.e., either trioctylphosphine 
oxide, TOPO, or ODA for ZnS-CdSe and Mn-ZnSe, respectively) was replaced with 
hydrophilic carboxyl groups using MPA as the ligand exchange reagent [170]. Similarly, 
micelle particles were obtained via the interfacial instability route [171] by evaporating 
chloroform solvent in the presence of particles and amphiphile in an aqueous emulsion.  
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Figure 8: Schematic of the ligand exchange process (top) and micelle-templated assembly 
of ZnS-CdSe QDs and Mn-ZnSe QDs (bottom). 
 
4.2 QD Size and Morphology 
Interestingly, the morphology of Mn-ZnSe QDs differs from that of traditional 
core/shell particles (Figure 9, Figure 10(e) vs. Figure 10(a)), which display a spherical or 
elongated oblong appearance. Mn-doped ZnSe QDs demonstrate a tetrapod shape, which 
has been reported previously for other semiconductor QD materials [172-175], but, to our 
knowledge, not for Mn-ZnSe QDs. This is in contrast to previous reports that indicated the 
formation of spherical QDs using a similar synthesis procedure [169, 170]. Nanostructure 
formation generally proceeds in two steps: nucleation and growth, which can occur 
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simultaneously in the same solution. Several factors influence the rates of these processes, 
including ratio of transition metal (e.g., Mn, Zn) to chalcogen (e.g., S, Se, Te), synthesis 
temperature, and the presence of impurities, including capping ligands, in solution. For 
tetrapods to form, anisotropic growth must occur. Usually, this results from the growth of 
one material phase (e.g., wurtzite) favored under certain synthesis conditions on a 
nucleated particle of a different material phase (e.g., zinc-blende) that was formed under 
different synthesis conditions. For example, CdTe tetrapods are initially nucleated with a 
zinc-blende structure containing four facets upon which growth of a nearly-lattice matched 
wurtzite structure can occur, yielding four arms, and therefore, tetrapod formation [172]. It 
is likely that Mn-ZnSe tetrapod synthesis begins with MnSe nucleation in the zinc-blende 
phase, as reported previously for spherical Mn-ZnSe nanoparticles [169] followed by 
growth of ZnSe arms in the wurtzite phase. Anisotropic growth is influenced by many 
factors, including the reactant ratio. Increasing the transition metal to chalcogen ratio 
favors growth over nucleation, enhancing anisotropic growth and tetrapod arm length [172]. 
In addition, selection of capping ligand is a strong influence on anisotropic growth, often 
favoring growth in a specific crystal plane, as shown by oleylamine-induced enhancement 
of growth in the [0001] direction in CdTe tetrapods [174] and the roles of phosphonic acid 
and hexadecylamine in the synthesis of CdTe [172] and CdS [175] tetrapods, respectively. 
In this work, a higher concentration of the additional zinc monomer was employed 
compared to the initially reported synthesis procedure [169]. This resulted in a higher Zn:Se 
ratio, which is most likely responsible for the observed Mn-ZnSe tetrapod structure; 
although, the higher concentration of octadecylamine (ODA) employed could also play a 
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role. Also, some tetrapods show branched arms (Figure 9(d)), as has been reported 
previously for other structures.[173] Generally, arms will continue linear growth if the 
material remains in the wurtzite phase; however, if zinc blende layers or stacking faults are 
present near the end of arms, a dendritic structure will emerge from the initial arms [172]. 
  
 
Figure 9: (a) Mn-doped ZnSe QDs. Particles adopt a tetrapod appearance (b, c), which 
can include arm branching (d). 
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Figure 10: TEM images of the particles. (a-d) ZnS-CdSe QDs. a) Organic QDs, b) 
commercial, water-soluble QDs, c) water-soluble QDs generated through ligand 
exchange, d) two examples of micelles formed from organic QDs; (e-g) Mn-ZnSe QDs. 
e) organic QDs, f) water-soluble QDs generated through ligand exchange, g) micelles. 
Inset shows the micelle indicated by the black arrow at 2X increased magnification. Scale 
bar = 100 nm for all images except inset. 
 
The average diameter of commercial, ZnS-CdSe QDs was determined to be ~8 nm, 
as indicated by TEM observations (Figure 10(b), (c)), and ~6 nm for Mn-ZnSe QDs (Figure 
10(e), (f)), consistent with previous reports [169]. It should be noted that organic ZnS-CdSe 
QDs displayed an elongated morphology (Figure 10(a)), but became spherical after the 
ligand exchange (Figure 10(c)). This might be caused by intraparticle ripening, which has 
been reported previously for these nanocrystals [176] and gold nanoparticles [177, 178]. 
Both types of particles (e.g., ZnS-CdSe QDs and Mn-ZnSe QDs) were incorporated into 
micelles, and several QDs were evident in each micelle (Figure 10(d), (g)). Micelle size 
was ~40 nm for ZnS-CdSe particles (Figure 10(d)) and ~30-50 nm for Mn-ZnSe particles 
(Figure 10(g)). Compared to micelles encapsulating ZnS-CdSe QDs, those encapsulating 
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Mn-ZnSe display an irregular shape, most likely resulting from the irregular shape of the 
tetrapod encapsulants. It is interesting to note that despite this irregularity, encapsulation is 
still possible. This result is consistent with reports of encapsulation of rod shaped-QDs in 
similar micelles [85, 179]. 
 
4.2.3 QD Optical Properties    
To evaluate the effect of micellarization on QD optical properties, micelle-
encapsulated Mn-ZnSe QDs (micelle) were compared to particles in the organic phase 
(organic) and to particles produced via ligand exchange with MPA (water-soluble-LE) 
(Figure 11(a)). Mn-ZnSe micelle particles displayed similar spectral properties to organic 
and ligand exchange QDs, including both absorption and emission spectra. The quantum 
yield of micelle-encapsulated Mn-ZnSe QDs was 26%, lower than that of the original 
organic QDs (40.7%) and QDs produced via ligand exchange with MPA (42.1%). 
For comparison, commercial organic CdSe-ZnS QDs were also modified using 
ligand exchange with MPA and micelle encapsulation to render them water-soluble 
(organic, water-soluble-LE, and micelle, respectively) and compared to commercially-
available water-soluble QDs (water-soluble-C) (Figure 11(b)). In all cases, virtually no 
difference between the spectra was seen, indicating that the ligand exchange and 
micellarization processes do not dramatically change QD absorbance and emission 
wavelengths. The quantum yield of the micelle-encapsulated CdSe-ZnS QDs was 26.4%, 
equivalent to that obtained for QDs produced via ligand-exchange QDs (25.3%), but lower 
than that of the original, organic QDs dissolved in chloroform (48.7%) and commercially-
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available water-soluble QDs (86%). 
 
 
Figure 11: Absorption and fluorescence spectra of (a) Mn-ZnSe-based and (b) ZnS-CdSe 
based particles. 
 
The loss of quantum yield observed upon micellarization of commercial ZnS-CdSe 
QDs most likely results from disruption of the surface ligands, which may change the 
blinking statistics as a result of changes in the local environment and/or surface traps. A 
similar loss was observed with the MPA ligand exchange method, consistent with this 
hypothesis. However, the fluorescence signal of Mn-ZnSe QDs is not believed to originate 
from trapped or surface states [170], and no loss of quantum yield is observed upon MPA 
ligand exchange, supporting this theory. Thus, it is likely that the diminution of quantum 
yield upon micelle encapsulation results from another cause, such as increased particle 
proximity, which may enhance particle-particle interactions and non-radiative energy 
transfer, or from the environmental conditions encountered during the micellarization 
process. However, as many QDs are incorporated in each micelle, micelle QDs still show 
much higher brightness than single QDs, as described below.  
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   To evaluate fluorescence dynamics, single particle fluorescence intensity of micelle 
Mn-ZnSe QDs was compared to that of organic and water-soluble QDs produced via ligand 
exchange (Figure 12(a)) as a function of time. For single QDs in both the organic and ligand 
exchange samples, fluorescence intensity fluctuated between ~0-600 a.u. (average intensity 
= 249 ± 115 and 218 ± 82 for organic and ligand exchange samples, respectively) with 
several instances that approached a value of zero, indicating blinking. However, the total 
fluorescence intensity of micelle particles always remained above zero (ranging between 
~600-1400 a.u.) and was ~4X that of individual QDs (average intensity = 979 ± 130).  
 
 
Figure 12: Fluorescence intensity for single QDs and QD micelles. (a) Mn-ZnSe-based 
particles. From top to bottom: Organic QDs, water-soluble QDs made by ligand 
exchange, and micelles. (b) ZnS-CdSe-based particles. From top to bottom: Organic 
QDs, commercial water-soluble QDs, water-soluble QDs made by ligand exchange, and 
micelles.  
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Similar results were observed for commercially-available ZnS-CdSe micelles 
encapsulated in micelles when compared to their organic QD precursors and water-soluble 
QDs produced via ligand exchange and water-soluble QDs sold commercially (Figure 
12(b)). Single QDs demonstrated variations in fluorescence intensity that resulted in 
multiple evidences of blinking (fluorescence intensity ranging from ~0-6700, ~0-6000, and 
~ 0-12000 a.u. for organic, ligand exchange, and commercial QDs, respectively), whereas 
micelle QDs demonstrate an ~ 4-13X increase in brightness (42382 ± 5494 a.u. vs. 3786 ± 
2137, 3230 ± 1750, and 8714 ± 3043 a.u. for organic, ligand exchange and commercial 
QDs, respectively) with no evidence of blinking (intensity ranging from ~26000-57000 
a.u.). The large difference in fluorescence intensity between the two types of samples 
examined, i.e., ZnS-CdSe and Mn-ZnSe, results from the different exciton fluorescence 
lifetime (a few ns for ZnS-CdSe QDs [180] and ~ 90 µs for Mn-ZnSe QDs [25], and the 
filter set employed which is only optimized for ZnS-CdSe QDs. 
The elimination of blinking behavior is the result of encapsulating multiple QDs within 
the same micelle core, and thus although individual QDs may lose fluorescence as a result 
of blinking, the ensemble continues to emit a continuous signal.[86] Increased brightness 
also results from the aggregation of multiple QDs within a micelle. It should be noted that 
the micelles reported here are ~ 40 nm in diameter (Figure 10) vs. 10-20 nm for 
commercially-available QDs, and micelle sizes can range from ~10-100 nm in diameter 
[78, 181]. Thus, this increase in fluorescence comes at the expense of only a marginal 
increase in nanoparticle size. These enhanced optical properties (i.e., reduced blinking and 
increased brightness) should significantly improve signal-to-noise ratio in tracking studies.  
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4.2.4 QD Stability to Photo-oxidation 
An important consideration for QD use in many super-resolution imaging methods 
is resistance to photo-bleaching, which permits signal to be collected for longer periods of 
time, increasing image resolution. Resistance to photo-oxidation is also an important 
consideration in reducing nanoparticle toxicity, as constituent atoms ejected during the 
oxidation process (e.g., Cd2+ for ZnS-CdSe QDs) can produce considerable toxicity in 
biological applications [182]. To examine the effect of micelle encapsulation on resistance 
to photo-oxidation, micelle Mn-ZnSe QDs were compared to organic and aqueous QDs 
produced via ligand exchange (Figure 13(a)). QDs were excited continuously using a 405 
nm LED with a power of 119 µW. Organic QDs demonstrated best overall performance, 
maintaining 60-70% of their initial intensity value over the time period investigated (~17 
min), whereas water-soluble QDs produced via ligand exchange demonstrated the worst 
performance, losing 50% of their initial fluorescence intensity value (i.e., I50) in the first 1-
2 minutes of exposure. In contrast, although micelle encapsulated QDs demonstrated an I50 
of ~ 2 minutes, there was very little additional loss of fluorescence over time. Thus, micelle 
encapsulation significantly improved resistance to photo-oxidation compared to QDs 
produced via the ligand exchange method, while yielding a water-soluble product suitable 
for biological imaging applications.  
In addition, the resistance to photo-oxidation of ZnS-CdSe QDs in micelles was 
examined and compared to that of QDs in the organic phase, rendered water-soluble 
through ligand exchange, and aqueous QDs sold commercially (Figure 13(b)). The 
fluorescence intensity of organic QDs, QDs rendered water-soluble through MPA ligand 
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exchange, and commercially-available water-soluble QDs rapidly declined, with I50 values 
of < 2 min. Micelle QDs demonstrated the best overall resistance to photobleaching, with 
no significant loss of fluorescence over the time period investigated (~ 17 min), although 
an I50 of ~ 30 min was measured in subsequent testing (Figure 14). Resistance to photo-
oxidation was dependent on the power and wavelength of incident light. For example, 
excitation with a 20 mW 488 nm laser source yielded I50 values of ~ 35 minutes for micelle 
encapsulated ZnS-CdSe QDs and ~ 8 minutes for commercially-available aqueous ZnS-
CdSe QDs. In both cases, the QD photo-oxidation rate was also dependent on the light 
exposure rate. QDs not continuously exposed were significantly more resistant to photo-
oxidation (data not shown).  
 
 
Figure 13: Photo-oxidization measurement. Each curve is normalized to the relative 
intensity at 0s. (a) Relative intensity of Mn-ZnSe QD micelles continuously exposed to 
excitation light of 405 nm. (b) Relative intensity of CdSe-ZnS QDs and micelles 
continuously exposed to excitation light of 405 nm. 
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Figure 14: Relative intensity of CdSe QDs mounted in DI water and continuously 
exposed to excitation light. Each curve is normalized to the relative intensity at 0s. ZnS-
CdSe QDs were mounted in deionized water and continuously excited with either 405nm 
or 488nm excitation light. The QDs were either water-soluble (Aqueous) or encapsulated 
in micelles (Micelle). The data for micelle encapsulated QDs is noisier than the data for 
the water-soluble QDs because they are less likely to adhere to the coverslip and are thus 
much more mobile over the course of the measurement. 
 
4.2.5 QD Photo-modulation 
 The fluorescence emission mechanism of doped-QDs has been previously reported, 
with significant differences from that of traditional core/shell QDs [170]. In doped-QDs, 
as in core/shell materials, an exciton, consisting of a hole in the valence band and an 
electron in the ZnSe conduction band, is generated through the absorption of a photon 
(Figure 15 (a)). However, unlike core/shell materials, the exciton rapidly transfers its 
energy to the dopant energy levels of the Mn2+ ions (4T1). At this point there are several 
possible outcomes. In the absence of additional energy input, the electrons will most likely 
decay radiatively to the 6A1 state and then return to the ground state, releasing photons. 
However, if additional energy is added, the electrons can be pumped into higher energy 
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states through excited-state absorption, from which they make radiation-less transitions to 
the ground state, effectively quenching fluorescence [183]. 
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Figure 15: (a) Schematic of the electronic transitions of Mn-ZnSe QDs, adapted from 
[25] (b) Fluorescence modulation of Mn-ZnSe QDs (top) and Mn-ZnSe QD micelles 
(bottom). (c) Modulation depth of Mn-ZnSe QDs as a function of 660 nm laser intensity. 
The emission is brighter at the focus of the modulating laser because the quantum dots 
fluoresce brighter when they are first excited. (d) Thin layer films of Mn-ZnSe QDs are 
excited with a 405 nm LED and modulated with a 660 nm laser (i) 0 MW/cm2 
modulation intensity, (ii) 0.625 MW/cm2 modulation intensity, (iii) 6.25 MW/cm2 
modulation intensity. (e) 5 cycles of modulation of Mn-ZnSe QDs micelles. The micelles 
are excited with a 365 nm LED, and modulated with a 660 nm laser as described in the 
methods. The modulation depth is 0.55 ± 0.02 and does not diminish over the course of 
the measurement (figure shown in next page) 
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Figure 15 
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Mn-ZnSe QDs can generally be excited at wavelengths shorter than 450 nm, 
yielding an emission peak centered at 580-600 nm (e.g., Figure 11(a)). By adding an 
additional excitation source at a longer wavelength (650-800nm), fluorescence emission 
can be suppressed [184], and therefore modulated. The ability of the investigator to control 
fluorescence signal potentially permits doped QDs to be employed in super-resolution 
imaging techniques, including Stimulated Emission Depletion (STED) Microscopy [185] 
and Structured Illumination Microscopy (SIM) [186]. 
There is some question as to whether micellarization could influence this process. 
In micelles, QDs are packed closely together, increasing the opportunity for interactions 
resulting from proximity. To evaluate this possibility, photo-modulation of unencapsulated 
Mn-ZnSe QDs was compared to that of QDs encapsulated in micelles (Figure 15 (b)). In 
this experiment, QD clusters were excited by a 119 µW 405 nm LED, while a 100 mW 660 
nm laser was employed as the modulation beam. When the 660 nm laser was off, QD 
emission was clearly evidenced in the excitation spot (Figure 15 (b), white arrows). 
However, when the 660 nm laser was applied, emission at the laser spot was suppressed, 
demonstrating the potential for investigator control of QD fluorescence emission. Results 
were similar whether particles were examined in a thick film (Figure 15 (b)), as might be 
expected in super-resolution imaging, or in thin films (Figure 15 (d)). This response also 
demonstrated reversibility and little change in modulation depth; even for particles that 
were several months old (Figure 15 (e)). The modulation depth of both materials was 
further investigated and found to be 76% and 79% for micelle encapsulated and doped QDs, 
respectively (Figure 15 (c)). From three separate measurements of the modulation depth 
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versus intensity, the modulation depth was found to be 0.72 ± 0.05 for intensities greater 
than 1.25 MW/cm2. (Modulation is a function of the modulating laser intensity and does 
not exceed 80% because the layer of QDs in the sample is thicker than the focal volume, 
so not all QDs in the region are modulated.) The modulation results, Figure 15 (b) and (e), 
are taken from a sequence of images in which the modulation laser is alternately off then 
on. After the modulation laser is turned off, the quantum dots fluoresce brighter than QDs 
that were continuously on. QDs are commonly measured to fluoresce brighter upon first 
excitation. The modulation depth is constant and does not increase or decrease as the 
modulation laser is cycled on and off, although the absolute brightness of the modulated 
particles both at “on” state and “off” state are enhanced, which is probably resulted from 
photobrightening [187]. Thus, micelle encapsulated QDs demonstrate nearly equivalent 
modulation depth to unencapsulated QDs, suggesting their potential application in super-
resolution imaging applications. 
 
4.3 Conclusion 
 Here, we demonstrate the influence of micelle encapsulation, an emerging water 
solubilization method, on two types of QDs: Mn-ZnSe QDs and core/shell ZnS-CdSe QDs 
with potential applications in super-resolution imaging. Interestingly, the Mn-ZnSe QDs 
employed demonstrated a previously unreported tetrapod shape, yet were still capable of 
being encapsulated via the micelle approach. Micelle encapsulation was shown to have 
little influence on QD absorbance or emission wavelength. However, micelle QDs 
displayed a 4-13X increase in brightness compared to organic QDs and QDs produced via 
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ligand exchange as a result of the micelle aggregation effect [86]. Additionally, micelle 
QDs demonstrated no observable blinking behavior, an important consideration for single 
particle tracking experiments. Micellarization was also shown to enhance resistance to 
photo-oxidation compared to other water solubilization methods, while not interfering with 
modulation depth. Additionally, micellarization is compatible with a wide range of QDs, 
including giant CdSe/CdS QDs, which have also been demonstrated for us in STED [188]. 
The potential for increased photon collection over a longer time period with QD 
micellarization should enhance image resolution compared to that obtained with QDs 
produced via ligand exchange. The combination of increased resistance to photo-oxidation 
and increased brightness makes micelle QDs attractive candidates for super-resolution 
imaging applications.  
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Chapter 5 Toxicity study of PS-PEO micelle template 
 Despite their extraordinary optical properties, QDs are not routinely used in 
biomedical research, and one of the major concerns is cytotoxicity. First, QDs, as nano-
sized materials, have potential yet less well understood toxicity than bulk materials [189]. 
More importantly, Cd2+ is a major component in most highly luminescent QDs that span 
the visible to NIR wavelength range. Cadmium is a notoriously toxic element that 
contributes to pulmonary disease, kidney injuries, bone deformations, neurological 
problems, and cancer [190]. At a cellular level, Cd2+ induces generation of reactive oxygen 
species (ROS), and may cause DNA damage. Therefore, it was not surprising when Derfus 
et al. first discovered QD (i.e., CdSe) toxicity in 2004 [191]. Since then, numerous 
researchers have investigated QDs toxicity. For example, the presence of free Cd2+ in 
cytoplasm was linked to cell death and decrease of metabolic activity, but free Cd2+ alone 
is insufficient to explain the total toxicity, and the presence of internalized QDs could 
contribute to the overall toxicity even if the entire surface is covered [192-194]. In fact, 
more research has correlated cytotoxicity with cellular uptake efficiency, and this 
information explains different toxicity levels of QDs with different sizes and surface 
ligands. Several groups have reported that negatively charged QDs (i.e., COOH group on 
the surface) have a significantly higher cellular uptake efficiency that accompanies a higher 
degree of toxicity than their neutral (i.e., PEG) or positively-charged (i.e., NH2) 
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counterparts [195-198]. This is probably because negatively charged particles are 
internalized through lipid raft meditated endocytosis, which is more efficient than clathrin 
dependent endocytosis that is primarily responsible for the transport of positively-charged 
QDs [197]. Besides QD internalization, aggregation state [199], protection layer (i.e., ZnS 
and PEG surface), surface ligand density [200], and photo-induced QD toxicity [201] have 
been investigated. Recently, cadmium-free QDs (i.e., InP or Mn-doped QDs) were 
developed as an alternative, which exhibited lower toxicity [202, 203]. Also, non-human 
primates studies have been performed that showed minimal toxicity during a 90 day period, 
but the longer term effect of QDs that were accumulated in the liver require additional 
study. 
 In Chapter 4, we investigated optical property enhancement of the (polystyrene-
polyethylene oxide) PS-PEO micelle coating. In this chapter, we focus on exploring its 
influence on cytotoxicity. Although QD cellular uptake is positively correlated to 
cytotoxicity, we do not propose to apply surface coatings (i.e., neutral passivated PEG 
coating) to reduce endocytosis, because, for imaging purposes, QDs usually need to be 
internalized into cytoplasm to be able to bind the biomolecule target of interest. In fact, cell 
penetration peptides are sometimes conjugated to QDs to facilitate the internalization 
process [204].  Since PS-PEO coating is efficient in protecting QDs from photobleaching, 
it may also be helpful to reduce QD cytotoxicity by keeping the QD inorganic surface intact 
and/or mitigating Cd2+ transport from the QD surface to cytoplasm. To evaluate this 
hypothesis, we applied three well-established assays on two types of QDs (CdSe/ZnS, Mn-
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doped ZnSe) with either mercaptopropionic acid (MPA) coatings or PS-PEO-COOH 
coatings. 
The MTT assay, a colorimetric assay routinely used for cell viability study and/or 
metabolism activity was used. In this assay, water soluble MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) is added to a cell mixture and converted to an 
insoluble formazan by NAD(P)H-dependent cellular oxidoreductase enzymes. The product 
is then solubilized (by organic solvent or surfactant), and has a strong absorbance at 570 
nm. For a specific cell type, the absorbance is proportional to the number of viable cells. 
The second assay employed was an ROS assay. Since one of the main toxicity mechanism 
of Cd2+ is through the production of ROS (primarily by reducing antioxidant enzyme 
activities, and the non-enzymatic component glutathione), this assay offers an indirect 
approach to assess intracellular [Cd2+]. The basic principle is to add dyes that only fluoresce 
upon reacting with ROS. The third assay employed was the TUNEL assay, used to 
distinguish apoptosis cell death from necrosis.  This assay is based on detecting DNA 
fragmentation caused by apoptotic signaling cascades. 
 
5.1 Material and methods 
5.1.1 Nanoparticle synthesis 
 CdSe/ZnS organic QDs were purchased from Life Technologies and Ocean 
Nanotech, and Mn-doped QDs were synthesized following the procedure detailed in 
Chapter 4. Note that QDs purchased from Life Technologies are reported in molar 
concentrations, thus, for consistency, we converted this to mass concentration via both 
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experimental and theoretical approaches. For the experimental method, 1 ml of commercial 
QD stock solution was precipitated with a mixture of 1.5X isopropanol and 3X methanol; 
the supernatant was discarded; and the QDs were dried under vacuum overnight. The 
remaining QDs were weighed to obtain a mass concentration of about 0.35 mg/ml. For the 
theoretical calculation, we first took TEM images and acquired the dimensions of the QDs 
(cylindrical QD605 with diameter = 2.7 nm and length = 9.1 nm), and assumed the density 
of the QD to be the same as bulk CdSe (5.82 g/cm3), and converted the molar concentration 
to mass concentration, which was ~ 0.18 mg/ml. Since we ignored the density difference 
between the CdSe core and the ZnS shell as well as the weight of surface ligands during 
the calculation, which may cause a significant error, we adopted the value acquired from 
the experiments for all mass concentration calculations. 
The ligand exchange methods and micelle coating methods are slightly different 
from chapter 4, and the new procedures usually yield more stable and reproducible 
products than reported in that chapter. For MPA ligand exchange, CdSe/ZnS QDs were 
transferred into chloroform by previously described methods at a concentration of 0.35 
mg/ml. 300 µl of QD solution and 30 µl of MPA were  mixed well, and sonicated for 1 
hour. The procedure for the doped QDs is the same expect 100 µl of the unpurified QD 
stock solution was used.  The product was precipitated via centrifugation, and washed once 
with chloroform. Then 500 µl of water and 5 µl of 1M NaOH solution were added to the 
solids to dissolve the QDs, followed by washing through a 100 kDa centrifugal filter, 3 
times before resuspension in cell media. 
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 For micelle encapsulation, higher molecular weight PS-PEO of 18k-b-9.5k instead 
of previously used 6.5k-b-3.8k was used to promote colloidal stability, and the PEO end of 
the polymer was modified with COOH to match the surface moiety of MPA, since surface 
charge is one of the key factors for nanoparticle cellular uptake. For CdSe/ZnS QDs, 100 
µl of 0.35 mg/ml QD chloroform solution and 10 µl of 20 mg/ml PS-PEO-COOH 
chloroform solution were mixed together in a 15 ml centrifuge tube, and 3 ml of 5 mg/ml 
PVA solution was added to the mixture to form an emulsion. The emulsion was sonicated 
for one hour to achieve a well dispersed emulsion droplet size distribution. Then interfacial 
instability took place while chloroform evaporated, leaving micelle-encapsulated QDs in 
the aqueous solution. For Mn-doped ZnSe QDs, a ligand exchange using 10% octanethiol 
was first applied using a similar process as for MPA ligand exchange, and washed by 
chloroform: acetone = 1: 2 mixture twice, before bringing to 0.7 mg/ml in chloroform for 
micelle encapsulation. This procedure was used to promote QD stability. Also, Mn-doped 
ZnSe QDs were not as stable as CdSe/ZnS QDs, so the total sonication time was reduced. 
To be specific, 50 µl of the as prepared QDs were mixed with 10 µl of 20 mg/ml PS-PEO-
COOH chloroform solution, sonicated for 10 min. After 2 min, air was blown on top of the 
open vial to facilitate evaporation, and all chloroform was removed from the solution 
within 10 min. Control samples (empty micelles) were prepared with the same procedure 
as used in CdSe/ZnS QD micelle encapsulation, except 100 µl of chloroform were added 
instead of the QD solution. 
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5.1.2 Toxicity assays 
HepG2 cells were used to evaluate QD toxicity in vitro. Cells were cultivated in 
improved minimum essential medium (MEM) with 10% FBS, 1% of 
penicillin/streptomycin (10k U/ml), and 0.2% of mycozap at 37 ˚C, 5% CO2. Cells were 
fed every other day, and passaged at ~ 80% confluency. 
MTT tests were performed with the Vybrant® MTT Cell Proliferation Assay Kit 
(V-13154, Life Technology). Briefly, cells were seeded in a 96 well plates at 5,000 cells 
per well with 5 replica at each concentration level. As prepared nanoparticle samples were 
brought to the right concentration with concentrated cell medium. After 24 h incubation, 
cell medium was removed and 50 µl of nanoparticle solution was added to the plate, and 
incubated with the cells for 24 h. Then the nanoparticles were removed, and 100 µl of 
phenol red free cell medium and 10 µl of 12 mM MTT solution were added to the plate 
and incubated for 4 h. Finally, 10% SDS solution was added to the plate to dissolve the 
formazan (converted from MTT by viable cells), and the product was evaluated at 570 nm 
using a microplate reader. 
 The ROS assay was performed with CellROX® Green Reagent (C10444, Life 
Technology). Cells culture and nanoparticle incubation were the same as in the MTT assay, 
except the seeding density is 20,000 cells/well. The stock ROS reactive dye solution was 
added to the cell medium at a final concentration of 12.5 µM. The dye was incubated for 
30 min, before washing with PBS twice. Then, the plate was measured using a fluorescent 
microplate reader under the FITC filter setting. 
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 The apoptosis study was performed using the Click-iT® Plus TUNEL kit, 
employing Alexa Fluor® 488 (C10617, Life Technology) kit. Cell culture and nanoparticle 
incubation were as described in the ROS assay (3 replica at each level), and stock solutions 
were prepared following according to manufacturer’s instructions. After treating cells with 
nanoparticles for 24 h, the cells were washed with PBS, fixed with paraformaldehyde, 
permeabilized with Triton X-100. Treatment for 1 hour with 10 unit/ml of DNase (Life 
Technologies, 18068-015) was used as a positive control. Cells were then treated with 
EdUTP nucleotide mixture and TdT (terminal deoxynucleotidyl transferase), labelled with 
Alexa 488 through copper (I) catalyzed click chemistry, and measured at the same 
conditions as in the ROS assay.  
 
5.2 Results and Discussions 
5.2.1 Preliminary study  
Since one purpose of this work is to study the effects of the PS-PEO coating on QD 
cytotoxicity, it is important to choose the right QDs to study. For example, ZnSe/ZnS or 
InP/ZnS QDs are less toxic than CdSe/ZnS QDs, and even different CdSe/ZnS QDs may 
have different toxicity depending on their size and surface ligands. Therefore, we might 
not be able to see the difference between MPA and PS-PEO coating over a short period of 
time. Therefore, we first did a screening of QDs from two different vendors with different 
sizes, and performed an MTT assay on these particles to identify the most toxic in native 
form (Figure 16). Clearly, QDs from Ocean Nanotech exhibited none or little toxicity 
compared to those from Life Technologies, even at higher concentrations. Since we do not 
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have synthesis information about these commercial QDs, it is hard to explain these 
difference at this stage. Nonetheless, we chose Life Technologies QDs for this toxicity 
study as the most toxic product evaluated, and therefore the product with the most potential 
for toxicity reduction via surface coating. 
 
Figure 16: MTT test of different types of CdSe/ZnS QDs (QD560, QD580, QD600 are 
from Ocean Nanotech, at 40 µg/ml and 200 µg/ml, respectively; and QD605 is from Life 
Technologies, at 20 µg/ml and 100 µg/ml, respectively) 
 
 The second issue encountered was the presence of a high PVA concentration in the 
micelle sample. PVA is used as a surfactant in the micelle synthesis procedure, and is 
present at concentrations much higher than the micelles themselves. Although PVA does 
not contribute significantly to cytotoxicity (Figure 17, ANOVA p>0.05), the presence of 
PVA prevents sample concentration through centrifugal filtration. This is because PVA has 
a large molecular weight (13k-23k), and cannot pass the centrifugal filters (100k) 
efficiently. As a result, the solution becomes a gel like substance that cannot be directly 
applied in this toxicity study. Previous methods used to remove PVA include washing 
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repeatedly at high centrifugal force (~ 20k rcf), but this procedure usually resulted in 
micelles aggregation and QDs irreversibly stuck to the filters. We found that the main 
reason for this loss was because of the high concentration of PVA clogging the centrifugal 
filters, and we solved this problem by diluting the solution ten times with water before 
washing. 1k rcf centrifugal force was enough to remove 90% of the PVA in a single wash, 
and after a few repeats of gentle washing, no PVA remains in the supernatant (verified by 
UV-vis spectrometry, 200 ~ 250 nm). 
 
 
Figure 17: Cell viability of PVA treated cells 
  
 Next, we ruled out the possibility that remaining chloroform may contribute to 
cytotoxicity. Since chloroform is used as a solvent during micelle encapsulation, and 
although chloroform dissolved in the solution should be removed during micelle 
purification, there is a chance that chloroform is also encapsulated in the hydrophobic core 
of the micelles, and may slowly release during the toxicity assay. Although chloroform has 
significant absorbance at 200 ~ 300 nm range, it is difficult to measure directly with a 
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spectrophotometer because of interference from other chemicals (i.e., PS-PEO, PVA). We 
adapted a qualitative assay from the literature [205] to a quantitative assay to determine the 
remaining chloroform concentration after purification steps. Briefly, 300 µl of sample was 
mixed with 200 µl of 50% NaOH solution in a 1.5 ml centrifuge tube, followed by adding 
250 µl of pyridine. Since PS-PEO has a much higher solubility in pyridine than in water, 
it is reasonable to assume most of the polymers would be transferred into the pyridine 
phase, leaving no chloroform molecules trapped in the micelles. The mixture was then 
vortexed at 2000 rpm for 1 min, and incubated in 90 ˚C water bath for 2 min. The mixture 
was swiftly transferred to a cooling water bath to stop the reaction. Then, the vial was 
centrifuged briefly to cause water/pyridine phase separation, and 50 µl of pyridine was 
transferred to another vial. This solution might be over-saturated with water, and might 
look turbid. To solve this problem, 150 µl of pyridine was added to the pyridine solution, 
and centrifuged at 20,000 rcf for 1 min. The supernatant was transparent with a pink to 
dark red color depending on the chloroform content in the sample. This supernatant 
solution has an absorbance peak at ~ 540 nm, and the chloroform concentration is linearly 
proportional to the absorbance, given that the chloroform concentration is between 20~100 
ppm (Figure 18, dilute or concentrate the sample if out of range). As a control, we tested 
pure PVA solution and PS-PEO solution (dissolved in pyridine), and neither of these two 
chemical contributed significantly to the signal. Note that it is possible to increase the 
sensitivity of the assay by heating the solution at a higher temperature and a longer time, 
and/or to use the NanoDrop system instead of a standard UV-vis spectrophotometer. Also, 
since the reaction could not reach equilibrium during the reaction time, it is critical to treat 
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each sample with exactly the same vortex speed and mixing time (preferably by putting all 
the vials in the same rack, and shaking the rack instead of individual vials). Using this 
approach, we calculated the effective chloroform concentration after the micelle sample 
was diluted with cell media, and it was less than 5.7 ppm, whose toxicity could be neglected. 
The MTT assay of empty micelle samples confirmed this result. Although ANOVA test 
shows p value equals 0.016, the difference among each groups are practically negligible 
(Figure 19). 
 
 
Figure 18: Calibration curve of chloroform concentration assay 
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Figure 19: Cell viability of empty micelle treated cells (the concentration represents the 
concentration of QDs these micelle would encapsulate with the standard recipe) 
  
 The last issue we encountered was that concentrating micelle-encapsulated QDs to 
a high extent would damage the particle and result in significant cytotoxicity. Initially, we 
prepared 10X more concentrated QD-micelle solution, and added 1/10 of the volume of 
the medium to the cell culture plate to achieve the desired concentration for cell culture. 
However, although the micelle solution showed little toxicity during at lower 
concentrations, there was an unexpectedly high toxicity at higher concentrations (Figure 
20). We attribute this abnormal increase of toxicity to particle damage caused by 
aggregation during preparation of 10X QD-micelle samples. To circumvent this issue, we 
prepared 1.4X QD-micelle samples, and added concentrated cell media to the QD sample 
to bring the final solution to 1X QD-micelle concentration and 1X cell medium 
concentration. 
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Figure 20: Cell viability of QD-micelle (concentrated) treated cells 
 
5.2.2 Toxicity study 
We first performed the MTT cell viability assay on both CdSe/ZnS and Mn-doped 
ZnSe QDs with either MPA or PS-PEO-COOH surface coatings (Figure 21).  
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Figure 21: MTT assay on 4 types of QDs: Top left: CdSe/ZnS QDs with MPA surface 
coatings; Top right: CdSe/ZnS QDs with micelle coatings; Bottom left: Mn-doped ZnSe 
QDs with MPA surface coatings; Bottom right: Mn-doped ZnSe QDs with micelle 
coatings. Groups with the same letter or no letter are statistically indistinguishable 
 
CdSe/ZnS-MPA QDs showed significant toxicity at all tested concentrations, and 
there is an obvious trend of more pronounced toxicity as QD concentration increases, 
which agrees with previous reports in the literature. We also showed that micelle-templated 
CdSe/ZnS QDs displayed no significant cytotoxicity in the MTT assay. Since the surface 
moieties of both the MPA ligand and the micelle are both the -COOH group, we expect 
similar surface charges, which results in similar cellular uptake efficiency (endocytosis). 
Therefore, the primary cause of the differential toxicity observed is probably the better 
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surface protection of the micelle over the MPA-coated QDs. First, QDs usually maintain 
best optical properties when their initial ligands are preserved. This is probably because 
during the ligand exchange process, both surface ligands (i.e., ODA and TOPO) and 
surface cations can be removed, and although the added ligands (i.e., MPA) can replace 
the original ligands, the loss of surface cations is likely irreversible [206, 207]. Second, the 
thick PS-PEO polymer matrix offers an additional layer to protect QDs from oxidation, 
and/or reduce Cd2+ diffusion from the QD surface to the cytoplasm. In addition, a few 
groups have reported that free [Cd2+] alone was insufficient to explain the toxicity of QDs, 
because QDs that exhibit the same level of toxicity usually have lower [Cd2+] than CdCl2 
solution that generates the same extent of toxicity [192, 193]. Micelle encapsulated QDs 
had no adverse effects on cell viability, suggesting that this micelle coating is beneficial in 
reducing the interaction between cytoplasm and QDs inside the micelles. 
Mn-doped ZnSe QDs (MPA) demonstrated no significant toxicity within 24 h at 
the maximum concentration of 25 µ/ml, which is a concentration sufficient for most 
bioimaging purposes. This is not surprising because of the lack of cadmium, and similar 
QDs have been reported to display low toxicity [202]. Mn-doped ZnSe QDs (micelle) 
showed no significant toxicity in some batches, but ~ 25% reduction in cell viability (25 
µg/ml) in others. Additional study is needed to evaluate this effect, significant toxicity 
would not be anticipated from Mn-doped ZnSe QDs, and especially after the micelle 
coating is applied, given our previous data with CdSe/ZnS QD toxicity (discussion below). 
We expect that these results were caused by insufficient removal of 1-octanethiol before 
the micelle encapsulation, but further experiments are needed to prove the hypothesis. 
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 To further investigate QD toxicity, we performed ROS assays on these QDs (Figure 
22). For QD-MPA treated cells, no significant degree of ROS signal (CdSe/ZnS-MPA, Mn-
doped ZnSe MPA QDs) was observed (ANOVA, α = 0.05). For QD-micelle samples, 
although a significant difference was detected via ANOVA, the level of ROS is too low 
compared to the positive control (100 µM Menadione for 1h) to make a meaning impact. 
The results were surprising, because CdSe/ZnS MPA-coated QDs clearly have a significant 
toxicity (viability ~ 50% under 25 µg/ml), and free Cd2+ is known to promote ROS [190]. 
Yet no ROS signal was observed. This was probably because the QDs impacted cells in 
alternative pathways other than ROS (i.e., cadmium can interact with DNA and replace 
zinc to deactivate some enzymes). 
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Figure 22: ROS assay on 4 types of QDs: A) CdSe/ZnS QDs with MPA surface coatings; 
B) CdSe/ZnS QDs with micelle coatings; C) Mn-doped ZnSe QDs with MPA surface 
coatings; D) Mn-doped ZnSe QDs with micelle coatings. The negative control is cells 
only (no particle, but treated with ROS dye), and the positive control is cells treated with 
100 µM Menadione solution for 1 hour. Groups with the same letter are statistically 
indistinguishable 
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 Lastly, we performed TUNEL assay on CdSe/ZnS QDs with either MPA or micelle 
coating (Figure 23). ANOVA testing indicates that no significant TUNEL signal was 
observed other than positive control (1 unit per ml of DNase for 0.5 h). The result was not 
surprising because in many cases apoptosis was accompanied by the generation of ROS, 
and we have shown the lack of ROS signal for all QDs treated cells. 
 
Figure 23: TUNEL assay. Left: CdSe/ZnS-MPA QDs; Right: CdSe/ZnS-Micelle. The 
negative control is cells only (no particle, but treated with TUNEL assay), and the 
positive control is cells treated with 1 unit per ml of DNase for 0.5 h. Groups with the 
same letter are statistically indistinguishable 
 
 
 
5.3 Conclusion and Perspectives 
 The initial intent of this research was to study the effects of PS-PEO-COOH micelle 
coatings on QD cytotoxicity, since it micelle-coated QDs exhibited extraordinary stability 
and optical properties in our previous work. This chapter shows that PS-PEO-COOH 
coated QDs are less toxic than those passivated with conventional MPA ligands. There are 
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two possible directions of research for future work. One direction is to perform a more 
detailed study of the effects of the PS-PEO-COOH micelle coating. For example, this 
research was based on the assumption that both MPA-coated QDs and PS-PEO-COOH 
coated QDs can be efficiently internalized by cells through endocytosis, since their sizes 
are in the endocytosis range, and they have the same end group on the surface. Our group 
has recently obtained datasupporting that micelle encapsulated nanoparticles can enter 
cytoplasm efficiently, but a quantitative study of the amount of internalized QDs (i.e., 
through confocal fluorescence microscopy or Inductively Coupled Plasma-Mass 
Spectrometry (ICP-MS) [208]) could add weight to the statement that the reduced toxicity 
was primarily caused by a better protected QD surface, rather than less internalization. 
 In addition, although MPA was a representative ligand once widely used in 
literature, there have been many types of new surface ligands that may also reduce QD 
toxicity. To claim a superiority of our micelle template over other surface coatings, it is 
important to compare to other ligands (for example, DSPE-PEG [78] and DHLA-PEG 
[209]). Our preliminary study indicated DSPE-PEG coated QDs showed greater toxicity 
than our PS-PEO micelle encapsulated QDs, although more experiments are required to 
substantiate this claim. Another direction would be to improve the micelle encapsulation 
scheme (i.e., types and/or molecular weight of polymers, loading capacity, surface charge, 
encapsulation methods) to produce non-toxic QD coatings that are stable in biological 
conditions (pH, ionic strength, enzymes) for sufficient period of time to enable elimination, 
so that QDs can be used clinically for in vivo diagnosis and therapy. 
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Chapter 6 Photoswitchable Nanocomposite Design 
Some of the content in this chapter was published in [210]. For DNA origami 
experiments, our group prepared DNA conjugated AuNPs, and the conjugation and 
characterization of DNA origami were performed by our collaborator Joshua Johnson from 
Dr. Carlos Castro’s group. 
Chapter 3 reviewed many photo-switchable QDs in the literature, and because of 
their deterministic switching mechanism, among other shortcomings, they cannot be 
applied to molecular localization-based super-resolution imaging (i.e., STORM/PALM). 
This chapter describes a novel design strategy for photo-switchable QDs with a potentially 
stochastic switching mechanism, presents preliminary results of this design, and discusses 
potential approaches for future optimization. In addition, this design involves the 
interaction between nanoparticles via a DNA linker that van be photo-activated, and 
therefore we extended this research to include nanoparticle – DNA origami interactions, 
which may shed light on future study of nano-factories and nanomachines.  
 
6.1 Photo-switchable Quantum Dots based on reversible FRET 
6.1.1 Design strategy 
 For the purpose of STORM imaging, an ideal QD would have a stochastic on/off 
switching mechanism with a high on/off ratio and most of the population being in the off 
state. The use of natural QD blinking would be an excellent approach to this problem except 
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that the off state duration is usually much lower than its on state counterpart. Researchers 
have proposed mechanisms responsible for QD blinking (i.e., Auger recombination and 
hot electron capturing), and have created methods to eliminate blinking [52, 211], but, to 
our knowledge, no research has ever produced stable QDs with enhanced blinking 
behavior. One obvious reason is that blinking is considered undesirable in most 
applications, so there is a lack of interest toward this research. Yet another reason derives 
from the nature of blinking, which is associated with charge traps and probably stacking 
faults during nanocrystal growth that may reduce QD stability. Oron et al. attempted to 
promote blinking by creating two exciton centers to enhance Auger recombination (2014 
Gordon Research Conference at Smithfield), the result was unsatisfactory. In summary, 
alternative strategies are desired until we can deliberately and controllably introduce 
defects in the nanocrystal while maintaining QD stability. 
 As reviewed in Chapter 3, most current approaches for constructing 
photoswitchable QDs rely on FRET from the QD to a quencher molecules that can change 
configuration and quenching efficiency in response to light. Because these approaches use 
multiple molecular quenchers per QD to achieve a good energy transfer efficiency, the 
stochastic property inherent in each molecular isomerization switch is averaged out. To 
circumvent this problem, we propose to use one powerful quencher per QD, and since 
FRET is strongly distance dependent, we can achieve a high quenching efficiency by 
varying the distance between QD and the quencher. 
 The first step is to choose the right quencher. Gold nanoparticles (AuNPs) are 
known as a good quencher when used in combination with QDs [212]. Here, we choose 15 
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nm AuNP as our quencher. Smaller AuNPs usually do not have sufficient quenching 
efficiency, and although larger AuNPs have a stronger quenching effect, the subsequent 
delivery to the cell would become more problematic with increasing size. Also, it should 
be noted that the interaction between QDs and AuNPs are not purely mediated by FRET. 
For example, for smaller AuNPs, the quenching efficiency is dominated by nanometal 
surface energy transfer (NSET), whose quenching efficiency is proportional to the 4th order 
of distance instead of 6th order, as in FRET. Moreover, at a relatively larger distance, 
AuNPs can enhance QD fluorescence instead of quenching it, because of the surface 
plasma resonance (SPR) enhancement [213]. Nevertheless, for 15 nm AuNP used as QD 
quenchers at a distance of few nanometers, FRET can adequately describe the interaction 
between the QD and the AuNP. 
 The second step is to establish a method of modulating the QD-AuNP distance by 
light. In chapter 3 we reviewed a few common types of photo-responsive molecules, among 
which the azobenzene-incorporated polymer can change its length in response to light 
[108]. However, there is only ~ 2.8 nm of change in length for an 88 nm polymer chain, 
which could only introduce a modest on/off intensity change. 
We found that azobenzene-modified DNA can undergo hybridization and 
dehybridization reversibly under UV/blue light, and we use these DNA molecules as 
linkers for our photoswitchable QD design (Figure 24). The photo-switchable system is 
composed of one green QD, one AuNP, and complimentary single stranded, azobenzene-
modified DNA (ssDNA) bound to each particle. Azobenzene groups adopt a trans 
configuration under blue light (>400 nm) and a cis form when irradiated with UV light 
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(300 ~ 400 nm) [117]. The trans configuration of azobenzene stabilizes hybridized DNA, 
so that under blue light the QD and AuNP are bound. QD fluorescence is thus quenched 
by the AuNP through FRET [212]. In contrast, the cis azobenzene conformation disrupts 
the double helix and induces dehybridization, so that QD and AuNP are not bound and are 
free to diffuse through solution. Because FRET is strongly distance dependent (i.e.,  1/r6, 
in this case, a few nanometers), QD fluorescence is restored. 
 
Figure 24: scheme 1 of photoswitchable QD 
 
One potential problem with the above design is that when DNA dehybridizes and 
AuNP diffuse away from QD, and the hybridization process will be hindered by the 
diffusion process. Here, we propose to link the two pieces of ssDNA with a non-reactive 
linker (e.g., a piece of polymer or a few ssDNA), and form a “loop” or “hairpin” structure 
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(Figure 25) so that after dehybridization the two nanoparticles are still tethered together, 
ready for conjugation.  
 
Figure 25: scheme 2 of photoswitchable QD 
 
6.1.2 Materials and methods 
The ssDNA used in all experiments were purchased from Sigma-Aldrich (Table 1). 
Specifically, azobenzene-based DNA (denoted as [azo]) was purchased from Sigma-
Aldrich, which used azobenzene phosphoramidite from Glen Research. For scheme 1, we 
examined an 8 bp linker pair (oligo 1 and 2) and a 12 bp linker pair (oligo 3 and 4, with 2 
non-complimentary T bases as a spacer),  
For scheme 2, we used oligo 5 with an inserted phosphoramidite spacer (denoted 
as [SP18]) as the loop (Figure 25), and dithiol-phosphoramidite (DTPA, Glen research) 
modification. 
 
  
loop
Complimentary 
sequence with 
azobenzene 
modification
QD (off)
QD (on)
AuNP AuNP
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Table 2: ssDNA sequence 
 5’ modifier Sequence (5’-3’) 3‘ 
modifier 
1 Amine GC[azo]GAGT[azo]CG  
2 Disulfide CGACTCGC  
3 Amine GTGCATGTAACG  
4 Disulfide TTCGT[azo]TAC[azo]ATG[azo]CAC  
5 Amine GC[azo]GAGT[azo]CG[SP18][SP18][SP18][SP18][SP18][SP18] 
[SP18][SP18][SP18][SP18]CGACTCGC 
DTPA 
 
6.1.2.1 QD-DNA-AuNP synthesis: scheme 1 
COOH-terminated QDs (maximum emission wavelength = 525 nm) were 
purchased from Life Technology. 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were purchased from Thermo 
Scientific, and other chemicals were from Sigma-Aldrich unless otherwise specified. DNA 
conjugation was performed as per a modification of the procedure of Xing et al, 2007 [214]. 
Briefly, 7.5 µl of 8 µM QD solution was mixed 1.5 µl of 2.2 mM EDC methanol solution, 
1.5 µl of 4.0 mM NHS methanol solution, and 4.5 µl methanol. The mixture was allowed 
to incubate at room temperature for half an hour, followed by addition of 6 l of 100 µM 
oligo 1 solution (QD: DNA = 1: 10) and 100 l phosphate buffered saline (PBS, pH = 7.4). 
The mixture was then mixed gently for 4 hours, and washed through a 50kDa centrifugal 
filter (Millipore, UFC505096) 3 times to purify unreacted oligo and other chemicals. 
We modified the surface of 15 nm AuNP with oligo 2 and 5 nm AuNP with oligo 
3. Both of these AuNPs were purchased from Nanocs, and the conjugation procedure for 
each was similar (adapted from Storhoff et al, 1998) [215]. These oligos have 5’ disulfide 
modifications, which were first reduced in a buffer of 100 mM dithiothreitol and 100 mM 
Sodium Phosphate (pH = 8.4) for 2 hours to yield thiol groups. Oligos were then purified 
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through a gel filtration column (NAP-10, GE Health). AuNPs and the reduced oligos were 
then mixed at a ratio of 1: 225 for 15 nm AuNP and 1: 25 for 5 nm AuNP, respectively. 
After incubating for at least 16 hours with mild agitation, the mixture was gradually 
brought to 0.1M NaCl, 10 mM Sodium Phosphate buffer (pH = 7.0) with concentrated 
buffer solution, and was then incubated for 24 hours. The conjugated particles were 
purified by centrifugation (20,000 rcf, 20~40 min) 3 times with 0.1M NaCl, 10 mM Sodium 
Phosphate buffer (pH = 7.0). After centrifugation, the red oily precipitate was resuspended 
in water, and the concentration was determined by absorbance at 520 nm (Thermo Electron 
Corporation Genesys 6 spectrophotometer). After purification, DNA-modified QDs were 
directly mixed with modified AuNPs (15 nm) at 1 nM for both nanoparticles, protected 
from light, and mildly agitated overnight before photo-manipulation. 
 
6.1.2.2 QD-DNA-AuNP synthesis: scheme 2 
 Bis (p-sulfonatophenyl) phenylphosphine dipotassium was mixed with 15 nm 
AuNP stock solution at a final concentration of 0.5 mM overnight, and then saturated 
sodium chloride solution was added to the mixture to precipitate the AuNPs. Oligo 5 was 
then added to the phosphine-coated AuNPs at 1: 1 molar ratio, and reacted overnight to 
form AuNP-DNA conjugates. EDC/NHS activated QDs (as in 6.1.2.1) were added to the 
mixture and gently mixed for 8 hours. The mixture was then diluted to ~ 1 nM for photo 
modulation.  
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6.1.2.3 Photo-modulation 
For both scheme 1 and 2, once the QD and AuNPs were conjugated, the solution 
was studied using a PTI QuantaMasterTM 40 fluorospectrometer. The excitation light also 
served as the modulation light, since QDs could be excited with both UV and blue light. In 
addition, QDs exhibit different fluorescence intensity under different excitation, so the data 
was normalized to reflect the intensity change that resulted from reversible quenching 
rather than different excitation wavelengths. 
 
6.1.3 Results and discussion 
We first examined the 8bp DNA linker system (scheme 1). Figure 26 (left) shows 
typical on/off switching kinetics, with an on/off intensity ~ 1.5. However, the modulation 
depth varies from batch to batch, for example, Figure 26 (right) shows the photo-
modulation of QDs synthesized with the same recipe, yet the on/off ratio is only ~ 1.15. 
 
Figure 26: on/off switching of QD with 8 bp linker from two different batches 
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To rule out the possibility that on/off switching another mechanism (i.e., blueing) 
instead of reversible FRET, we monitored the spectra during the first switching cycle, and 
there was no peak shift during the process (Figure 27), confirming that bluing did not occur. 
 
Figure 27: switching on (left) and off (right) fluorescence spectra 
 
The irreproducibility and the lower than expected modulation depth is likely to be 
caused by the fact that not all of the QDs and AuNPs were bound together in the “off” state, 
which was confirmed by TEM (Figure 28). 
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Figure 28: TEM of photoswitchable QD at off state 
 
There are at least three possible reasons for the low binding efficiency and slow 
on/off switching. First, QDs may have insufficient colloidal stability. Second, the 8 bp 
DNA linker is too short to remain stable. Third, the slow switching kinetics may result 
from insufficient modulation light.  
We examined all three possible causes, and we believe the first cause is the 
bottleneck of the unsatisfactory performance. Since the photoswitchable QDs were 
measured in a fluorospectrometer, and AuNPs have strong absorbance at UV-blue range, 
the concentration of the QD must be low enough (i.e., a few nanomolar) to avoid the inner 
filter effect to allow the modulation light to penetrate into the solution. However, the 
commercial QDs are quite unstable at low concentrations, and there is a steady decrease in 
fluorescence once the QDs (without AuNP or DNA conjugation) are diluted in 1 nM water 
solution. Since a decrease in QD fluorescence is usually accompanied with a loss of surface 
ligand and/or surface oxidation, we expect a reduction of QD-DNA binding even if the 
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conjugation chemistry is performed successfully. Therefore, only a small part of the QDs 
may have the ability to bind AuNPs and respond to photo-modulation.  
We have made a few attempts to address this problem. The first method was to find 
optimal conditions to preserve QD fluorescence. We purged the solution with inert gas 
(Argon and Nitrogen) to prevent oxidation, but no significant improvement was observed. 
Applying oxygen scavengers (glucose oxidase and catalase) [216] almost instantaneously 
quenched QD fluorescence even at normal concentrations. We also tried to identify a 
compatible buffer to dilute QDs, yet water was identified as the best solvent for QDs 
because QDs cannot withstand high ionic strength at low concentration. A different 
approach was to use more stable QDs to start with. However, little success was achieved 
with commercial QDs, either with different surface coatings (e.g., streptavidin) or from 
different vendors (e.g., Ocean Nano, NN-lab). 
In 2012, Deng et al. proposed a new method to produce robust QD-DNA conjugates 
[93]. The core of the QD (e.g., CdTe, CdSe, or alloyed CdZnSSe) was first synthesized in 
organic solvent, and after MPA-facilitated transfer into the aqueous phase, DNA oligos 
were embedded into the nanocrystal lattice during shell (e.g., ZnS) growth. We first tried 
to reproduce this procedure by synthesizing a CdZnSSe alloyed core, and achieved a 
quantum yield of ~ 45% (Figure 29), but the fluorescence declined signficantly during 
phase transfer, and could not be fully recovered during shell growth. Later, we modified 
this procedure and grew an additional layer of ZnS for DNA embedding upon commercial 
CdSe/ZnS core/shell QDs. The product QDs showed significant stability enhancement over 
their non-DNA conjugates, which indicated successful DNA embedding. In future work, I 
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suggest transferring this improvement in QD-DNA conjugation to the photoswitchable QD 
system. 
 
 
Figure 29: UV-vis and PL spectra of the alloyed QD (CdZnSSe) 
 
We also tried to study the second possible cause by replacing the unstable 8 bp 
DNA pair with a 12 bp oligo linker. We used 12 bp oligo 3 and oligo 4 to modify the QD 
and the AuNP surface, respectively, and observed a similar degree of photo-modulation 
(Figure 30), but with poor reproducibility, which indicated that the stability of QDs 
probably plays a more vital role than other factors. 
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Figure 30: on/off switching of QD with 12 bp linker 
 
Besides the binding efficiency, another factor that may contribute to the low 
modulation depth is azobenzene modulation. We observed that during the switching on 
cycle, increasing the modulation intensity can facilitate the switching on process (Figure 
31). Given our limited instrumentation, it is possible that even at the strongest light 
intensity attainable from a fluorospectrometer, the modulation intensity may not be 
adequate to fully cause DNA dehybridization, therefore limiting the number of 
photoswitchable QDs that could be turned on in this configuration. 
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Figure 31: switching on speed vs. modulation intensity 
 
Lastly, we briefly examined the performance of photoswitchable QDs with a loop 
linker. The stem part of the hairpin DNA was adapted from the 8 bp complimentary 
sequence, and an additional PEG linker was inserted in between so that the average distance 
between QD and AuNP is > 10 nm, when QD fluorescence is in the AuNP SPR 
enhancement region [213]. We first estimate the contour length (L) of the chain. Assuming 
commercial QDs  have a shell 5 nm in thickness, then the average end to end distance ree 
should be at least 5 nm. Also, considering that photo-switchable QDs are targeted to a 
desired location using biomolecules, one end of the chain should be fixed, and since the 15 
nm AuNP has a non-negligible volume, the classic worm-like chain model may not 
describe the situation precisely. Here, we apply the model developed by Segall et al. [217] 
that assumes one end of the chain is tethered to a plain and the other end is tethered to a 
large particle. The contour length was then estimated with the following equation: 
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in which ξ represents the persistent length of the ssDNA, and L is the contour length of the 
ssDNA. NR is defined as 𝑅/√𝐿𝜉/3 in which R is the radius of the AuNP (7.5 nm), and erf 
denotes the error function. The persistence length of PEG is adopted as ξ (0.38 nm) since 
the spacer takes up the most of the contour length and the average persistence length should 
be closer to that of PEG instead of ssDNA. For our designed oligo 5, the contour length is 
~ 37 nm, and ree is 5.3 nm, so that the distance corresponds to the enhancement region. 
Unfortunately, this scheme only showed a slight modulation depth (Figure 32), probably 
because of the problems mentioned above. 
 
Figure 32: on/off switching of QDs with a loop DNA linker 
 
6.2 Nanoparticle – DNA origami interaction 
6.2.1 Introduction 
In the last few decades, structural DNA nanotechnology has allowed the assembly 
of precisely designed objects, including nanocages, nanotubes, and nanopores with typical 
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dimensions in the range of 1-100nm [218, 219]. These structures are fabricated via 
molecular self-assembly that is programmed through DNA sequence design to achieve a 
specific geometry. The development of scaffolded DNA origami [220] has enabled the 
fabrication of nanostructures that approach the geometric complexity of natural 
biomolecular machines. Recently, DNA origami nanostructures have demonstrated 
promise for molecular sensing [221, 222], structural biology [223], and drug delivery 
applications [224, 225], among others [226, 227]. Although nanoparticles have previously 
been combined with DNA origami features through DNA hybridization [228-232], 
azobenzene-modified DNA has not yet been employed as a linker. Therefore, integrating 
azobenzene DNA into the DNA origami platform provides the potential for photo-
manipulated functionality in future DNA machines. In this work, we have demonstrated 
the ability to conjugate nanoparticles with a hinge-shaped DNA origami (Figure 33), and 
the ability to control the open angle distribution of the hinge with nanoparticles. 
 
Figure 33: overview of AuNP attachment to origami with different binding sites 
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6.2.2 Materials and methods 
6.2.2.1 DNA origami synthesis (synthesized by collaborator by Joshua Johnson from Dr. 
Castro’s group) 
DNA origami hinges were folded based on a previously characterized design [233]. 
Briefly, hinges were folded in a solution of 20 nM m13mp18 scaffold DNA, 200 nM of 
each staple strand, 1 mM EDTA, 5 mM NaCl, 5 mM Tris, and 18 mM MgCl2. Hinges were 
tested in a rapid (4 hour) fold using a thermal gradient and characterized via gel 
electrophoresis to determine an optimum folding temperature. A temperature of 53°C was 
found to be suitable for obtaining high yields of the hinge. A 0.4 mL solution of each hinge 
type was incubated in a standard heat block to 65°C for 15 minutes to melt away undesired 
secondary structure formation, incubated at 53°C for 4 hours then cooled to 4°C before 
verifying proper folding using 2% agarose gel electrophoresis. The folding solutions were 
purified using PEG-based methods similar to [234]. Specifically, the hinge folding reaction 
mixtures were mixed with an equal volume of 15% PEG 8000. The solutions were 
centrifuged at 16000xg for 30 minutes to separate the excess staple strands. The pelleted 
structures were re-suspended 400 µL 1x TAE buffer with 12.5 mM MgCl2. The solution 
was then centrifuged at 16000xg for 30 minutes, the majority of the supernatant removed, 
and then re-suspended with 100 µL of 1xTAE with 12.5 mM MgCl2. The resulting purified 
solution was characterized with 2% agarose gel electrophoresis and compared against the 
initial folding reactions to verify all unreacted staples had been removed. The final hinge 
solutions were diluted to 4 nM as measured by UV absorbance on a Thermo Scientific 
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NanoDrop 2000 and imaged with an FEI Tecnai G2 spirit TEM. Negative Uranyl-Formate 
(UFo) staining was used when preparing TEM grids as detailed in [235]. 
 
6.2.2.2 AuNP-DNA conjugation 
 The conjugation of 15 nm AuNPs to DNA proceeded as described in 6.1.2.2. In this 
study, 5 nm AuNP was also used, and the AuNP: DNA ratio was 1: 25. Both AuNPs types 
were purified using a 50kDa Amicon centrifuge filter at 7000 rcf for 5 min, then rinsed 
with 1xTAE with 12.5 mM MgCl2 at least 4 times. 
 
6.2.2.3 Construct formation 
All hinge solutions were diluted to 4 nM and all AuNP solutions were diluted to 20 
nM and characterized via UV-Vis absorbance spectra. Equal volumes of hinges and 
nanoparticles were mixed for all solutions characterized in this work. Solutions held at 
elevated temperatures were heated in a thermocycler for a specified amount of time then 
cooled to 4°C before depositing onto a TEM grid for imaging.  
Samples were processed using 2% agarose gel at 100V for 1 hour to purify from 
excess AuNPs. The bands corresponding with primarily bound hinges were isolated and 
spun in a freeze and squeeze column at 10000xg for 10 minutes. The percentage of bound 
particles were then verified via TEM. For sites 2 through 4 the structures had sufficiently 
different electrophoretic mobility to structures that did not have a nanoparticle bound to 
both sides of the hinges. 
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6.2.3 Results and discussions 
The hinges were designed so that, for a specific binding site, both sides of the hinge 
have ssDNA overhangs complimentary to the DNA sequence on the AuNP. Therefore, 
AuNPs can be conjugated with the DNA origami to “close” the hinge. Since AuNPs occupy 
a certain volume, the position at which the AuNP is inserted will determine the hinge angle 
or at least the range of angle distribution. 
For a specific hinge, there are 4 possible configurations: open, single bound, double 
bound, and closed (one AuNP binds to both sides of the hinge). In Figure 34, angle 
histograms of the closed configuration were fit to a Gaussian distribution. The average 
measured angle decreases as nanoparticles bind to sites farther away from the hinge vertex. 
In addition, the root mean squared deviations around the average angle decreased 
demonstrating that both can be tuned as a function of nanoparticle size and binding site. 
This figure clearly demonstrated the ability of nanoparticles to interact with DNA origami 
nanostructures. 
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Figure 34: Angular distribution fit to  a Gaussian function for all binding sites with 
respective TEM images. Scale bar is 50 nm. 
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Chapter 7 Conclusions and Future Directions 
7.1 Summary of dissertation 
 This research was aimed at developing photo-switchable QDs for super-resolution 
fluorescence microscopy, which included 1) improving the optical properties and 
biological compatibility of existing QDs (Chapter 4-5), and 2) designing novel photo-
switchable QD probes (Chapter 6). 
 In Chapter 4, we synthesized photo-switchable Mn-doped ZnSe QDs in the organic 
phase, and encapsulated these QDs in a micelle template. As a comparison, we coated these 
QDs with mercaptopropionic acid (MPA), and treated conventional CdSe/ZnS QDs with 
the same coatings. Our results showed that the micelle template not only preserved QD 
fluorescence and photo-switchable properties, but also reduced QD blinking, increased 
individual assembly brightness, and increased resistance to photobleaching. Therefore, 
these micelle templated QDs are good candidates for QDs application in bioimaging and 
molecular/cellular tracking. 
 In Chapter 5, we investigated the impact of micelle encapsulation on cytotoxicity. 
For Mn-doped ZnSe QDs, no significant toxicity on HepG2 cells was observed either with 
conventional MPA coatings or micelle coatings. For CdSe/ZnS QDs, micelles can 
significantly reduce QD toxicity. This likely resulted from the additional thick layer of the 
micelle coating protecting QDs from the adverse environment in the biological system, and 
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also reduction of Cd2+ diffusion to the cytoplasm. Surprisingly, the loss of cell viability 
was not caused by the generation of reactive oxygen species (ROS), and the cell death was 
not caused by apoptosis. 
 Chapter 6 described the design of a novel type of photo-switchable QDs. This 
design was primarily based on gold nanoparticle (AuNP) quenching of QD fluorescence 
via Förster resonance energy transfer (FRET) and azobenzene-modified DNA linkers for 
photo-switching. These QDs are intrinsically different from the ones previously reported 
in the literature, which had deterministic on/off kinetics, and cannot be used in Stochastic 
Optical Reconstruction Microscopy (STORM). By using a highly efficient quencher 
(AuNP), our design eliminated the need for multiple quenchers per QD, and therefore had 
the potential to be modulated on/off stochastically, a prerequisite for STORM. 
 In addition, inspired by the azobenzene modified DNA linker and recent 
developments in DNA origami, Chapter 6 explored the potential of combining 
nanoparticles and DNA origami templates to build functional nanocomposites. These 
composites have the functionality of nanoparticles (i.e., fluorescence, magnetic properties, 
surface plasma resonance, etc.), and the precisely tailored nano-structures provided by 
DNA origami. This chapter applied AuNPs to a hinge shaped DNA origami structure, and 
preliminary results supported that the hinge angular distribution could be modulated by 
inserting AuNPs at different locations. 
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7.2 Future directions 
7.2.1 QDs application in biological system 
 Ideal fluorescent probes for biological systems should have the following 
characteristics: 1) bright emission (high quantum yield and large cross sectional extinction 
coefficient), 2) ability for multichannel imaging (large Stokes shift and narrow emission 
peaks), 3) photo-stability, 4) colloidal stability, 5) efficient transport in biological systems, 
and 6) minimal interference of cellular bioactivity. QDs as alternative fluorophores to 
molecular dyes and fluorescent proteins usually excel in the first 3 properties. The colloidal 
stability of QD is primarily determined by surface chemistry, and is largely dependent on 
the QD concentration used in the system. However, QD transportation is a major 
shortcoming compared to molecular dyes and fluorescent proteins because of their large 
hydrodynamic sizes. Lastly, cadmium-based QDs usually exhibit cytotoxicity, whether 
acute or chronic; and QDs may adversely affect the target of interests, since QDs have sizes 
comparable to or larger than many functional proteins. 
 Our research developed micelle surface coatings that enhanced QDs brightness, 
photo-stability, colloidal stability, and toxicity, leaving multiplexing ability unchanged, but 
their increased sizes may have adverse effects on QD transportation. These negative effects 
are less important when studying tissues or cell surfaces, but may limit their applications 
in the cytoplasm. Therefore, future research should include a deeper understanding of 
micelle structures, and develop more compact QD surface coatings while preserving all the 
enhanced properties achieved in this research. In a separate direction, studying novel QD 
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intracellular delivery methods (e.g., microfluidic-facilitated QD delivery system [236]) 
will be beneficial for the application of QDs in biological systems. 
 
7.2.2 QDs in super-resolution imaging 
 In Chapter 6 we described the design of reversible, FRET-based, photo-switchable 
QDs. Although this design offers stochastic on/off switching and is intrinsically different 
from other photo-switchable QDs in the literature, our results only showed a 1.5 on/off 
contrast, which is insufficient for STORM imaging. Future research should aim to solve a 
few of these obstacles with newly reported methods. The current limiting factor of our 
design is insufficient colloidal stability at low concentration. There are three possible 
approaches that may solve this problem. The first approach is to find amphiphilic 
molecules that have a very low CMC (critical micelle concentration), so that the micelle-
QD assemblies are stable at low concentration; the second approach is to use multi-dentate 
ligands for surface modification [70-72]; and the third method is to embed ligands inside 
the ZnS shell rather than on the surface [93]. The second or the third methods are expected 
to be preferable, because micelle coating usually results in a thicker shell, which may 
decrease quenching efficiency and therefore the on/off contrast. 
 The second issue to be addressed is the relatively low on/off switching kinetics. 
This process could potentially be accelerated by changing the DNA sequence (CG/TA 
ratio, DNA length, azobenzene insertion positions). In addition, Yoshimura et al. 
incorporated the photo-reversible 2+2 cycloaddition reaction into a DNA sequence, and 
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achieved fast hybridization/dehybridization with UV light [122], which offers an 
alternative to azobenzene-based photo-modulation. 
 Although our photo-switchable QDs were designed for STORM imaging, they 
could be used in other super-resolution imaging techniques, such as SOFI (super-resolution 
optical fluctuation imaging) [35] or QDB3 (3D Super-Resolution Imaging with Blinking 
Quantum Dots) [37]. Both techniques use natural QD blinking and do not require complete 
on/off switching or the majority fluorophores to be in the dark state, as required in STORM. 
Therefore, even if our design could not achieve complete on/off switching, it could enhance 
the performance of SOFI and QDB3 as long as there are enhanced intensity fluctuations 
over QD natural blinking. 
 Lastly, this research combining functional nanoparticle and DNA origami is still in 
its seminal stage. Following this work, we will first explore the conjugation kinetics 
between nanoparticles and DNA origami, and will apply environmental stimuli (i.e., light, 
magnetic field, etc.) to manipulate the conjugation state of nanoparticles, thereby 
modulating hinge angular distribution. 
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Appendix A: Synthesis of Mn doped ZnSe QDs 
Purpose:  
This document describes the procedure to synthesize Mn doped ZnSe quantum dots 
in organic solvent and the procedure to transfer the organic quantum dots into aqueous 
phase through ligand exchange process or PS-PEG micelle encapsulation. 
 
Safety Precautions and PPE: 
 Tetramethylammonium hydroxide is highly toxic and corrosive, and it should be 
and opened in fume hood; 
 Tributyl phosphine is highly flammable and toxic, and it should be stored in 
glovebox and handled under inner gas (glovebox/Ar flow); 
 Acetone, chloroform and methanol are volatile and flammable, and it should be 
stored in flammable cabinet and opened in fume hood;  
 3-Mercaptopropionic acid is toxic and corrosive; and it should be and opened in 
fume hood; 
 The heating reaction has a potential explosion hazard. Make sure the reaction 
system has an open end; 
 The product (Mn-ZnSe quantum dots) might be toxic. 
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PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. Operations should be conducted in a glovebox or a fume hood. 
 
Step one: synthesis of MnSt2 precursor 
Manganese stearate (MnSt2) is now commercially available. But all the MnZnSe 
quantum dots (QDs) synthesis experiments were performed with MnSt2 prepared in the lab. 
 
Materials 
 100 ml three-neck flask 
 Heating mantle and temperature controller 
 Magnetic stirrer and stir bar 
 50 ml centrifuge tubes 
 Centrifuge (Eppendorf) 
 Vacuum oven 
 Stearic acid (SA), Grade I, ≥98.5% (capillary GC), Sigma-Aldrich 
 Tetramethylammonium hydroxide (TMAH), 25% w/w in methanol, Alfa Aesar 
 Manganese chloride, 97%, Alfa Aesar 
 Methanol, >=99.9% (for HPLC), Sigma-Aldrich 
 
Procedures 
1. Weigh SA 1.42g in a 100 ml three-neck flask. 
2. Add methanol 10 ml in the flask. 
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3. Heat to 50~60 ˚C until it becomes transparent solution. 
4. Cool to room temperature, and there are white precipitates. 
5. Mix 2.3 ml of TMAH and 1.5 ml of methanol, add the mixture dropwise to the SA 
solution until all the white precipitates disappear.  
6. Add a very small amount of SA and stir for at least 10min. At this time, there is a 
little white solid in the flask. Add 30 ml methanol to dissolve the solid. 
7. Dissolve MnCl2 0.315g in methanol 3.15 ml; add the solution dropwise (very 
slowly), and white precipitates should flocculate; stir vigorously. 
8. After the reaction, pour 30 ml methanol into the flask. 
9. Evenly distributes the liquid with four 50 ml centrifuge tubes, and add methanol to 
fill it before centrifuge. 
10. Wash the precipitate with methanol for 6 times. 
11. Dry the product in vacuum overnight (vacuum oven, room temperature) 
 
Step two: synthesis of organic Mn doped ZnSe quantum dots 
Mn doped ZnSe quantum dots are synthesized in organic phase. 
 
Materials 
 100 ml three-neck flask 
 50 ml three-neck flask 
 25 ml three-neck flask 
 15 ml three-neck flask 
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 Heating mantles and temperature controllers (2 sets) 
 Heat gun 
 Cotton 
 Magnetic stirrer and stir bar 
 Vacuum/Inert Manifold 
 Argon gas cylinder 
 Glovebox (Argon) 
 Heat proof syringes 
 octadecene (ODE), ≥95.0% (GC), Sigma-Aldrich 
 Selenium (Se), 99.999%, ~200 mesh, Alfa Aesar 
 Tributyl phosphine (TBP), 97%, Sigma-Aldrich 
 Octadecylamine (ODA), 98%, Alfa Aesar 
 Zinc stearate (ZnSt2), ZnO 12.5-14%, Alfa Aesar 
 Methanol,  >=99.9% (for HPLC), Sigma-Aldrich 
 Chloroform, AR (ACS), Mallinchrodt Chemicals 
 Acetone, >=99.9% (for HPLC), Sigma-Aldrich 
 
Procedure 
1. Prepare Sn-TBP solution: mix 0.63 g Se with 2.7 ml TBP in glovebox (read SOP 
for glovebox before experiment) 
2. Prepare Sn-TBP-ODA solution: mix 1.5 ml Sn-TBP solution with 1.3g ODA (in a 
25 ml flask) in glovebox 
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3. Load 25 ml ODE and 0.1 g of MnSt2 into a 100 ml three neck flask, heat to 110°C 
with magnetic stir and keep for 20 minutes under Argon bubbling. 
4. Transfer the Sn-TBP-ODA from glovebox to fume hood, and connects with 
manifold filled with Ar. Note: DO NOT apply vacuum when remove Sn-TBP-ODA 
from glovebox, or otherwise TBP will evaporates. 
5. Heat Sn-TBP-ODA mildly (~70˚C) until melt. 
6. Insulate the flask with cotton. Set T=290˚C, and swiftly inject all of the Se-TBP-
ODA solution when T reaches 280˚C. 
7. Set the temperature to 260˚C; stay there for 60 min. 
8. Prepare ZnSt2 solution: add 2.5g ZnSt2, 0.5g stearic acid, and 12 ml ODE in a 50 
ml flask. Connect the flask to manifold, and heat the mixture to 150˚C with stir. 
9. Set the temperature to 300˚C, and inject 4 ml ZnSt2 solution (warm the syringe with 
heat gun when T=285˚C) when T reaches 290˚C; 
10. After 15 minutes, inject the rest ZnSt2 stock solution into the reaction flask, in 3 
ml/15 min intervals for 3 times. Decrease the temperature to 260°C, and inject 0.6g 
ODA in 0.6 ml ODE (mixed in a 15 ml flask and melt with heat gun). 
11. Stop heating and cool the reaction to room temperature. Store the unpurified 
quantum dots in 4°C (this is the most stable form). 
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Step three: quantum dots purification 
The purified quantum dots can dissolve in several organic solvents including but 
not limited to chloroform, hexane, decane and toluene. 
 
Materials 
 15 ml centrifuge tubes 
 Centrifuge (Eppendorf) 
 Heat gun 
 Chloroform, AR (ACS), Mallinchrodt Chemicals 
 Acetone, >=99.9% (for HPLC), Sigma-Aldrich 
 
Procedures 
1. Heat the unpurified quantum dots mixture mildly with heat gun. 
2. Add 1 ml quantum dots to a 15 ml centrifuge tube. 
3. Add 1 ml chloroform and heat the mixture mildly with heat gun until it become 
transparent solution. 
4. Add 2 ml acetone and the quantum dots precipitate. Heat the mixture mildly again. 
5. Apply centrifugation, and decant the supernatant. 
6. Repeat 3~5 two or three more times. 
7. Dissolve the quantum dots in desired organic solvent (e.g. 1 ml chloroform for step 
four). 
 
134 
 
Step four: quantum dots MPA ligand exchange 
The purified quantum dots are transferred into aqueous phase through MPA ligand 
exchange. 
 
Materials 
 1.5 ml centrifuge tubes 
 Centrifuge (Eppendorf) 
 Chloroform, AR (ACS) 
 3-Mercaptopropionic acid (MPA), >=99%, Sigma-Aldrich 
 Sodium bicarbonate (NaHCO3), Sigma-Aldrich 
 
Procedure 
1. Mix 100 µl quantum dots – chloroform solution with 20 µl MPA in a 1.5 ml 
centrifuge tubes. 
2. Vortex for 20 minutes and the MPA modified quantum dots precipitate. 
3. Apply centrifugation, and decant the supernatant. 
4. Wash with 100 µl chloroform one more time and separate with centrifugation. 
5. Dissolve the purified QDs in water (add NaHCO3) to facilitate dissolution. 
 
Step five: PS-PEG micelle encapsulation (circumvolving method) 
The purified quantum dots are transferred into aqueous phase PS-PEG micelle 
encapsulation 
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Materials 
 10 ml glass vial 
 PS-PEG (3800-b-6500), Polymer Source (10 ug/ml in chloroform) 
 Poly (vinyl alcohol) (13,000-23,000 Dalton, 87-89% hydrolyzed) 
 
Procedure 
1. Mix 100 µl QD solution with 10 µl polymer solution in a 1.5 ml centrifuge tube 
2. Add 800 µl 5% PVA aqueous solution  
3. Vortex for 2 minutes at 3,000 rpm 
4. Transfer the mixture to a 10 ml glass vial, and circumvolve the vial to dry up 
chloroform (for 5 min). The solution should become less turbid and the micelle is 
formed. 
 
Reference 
1. Peng, X.G. and N. Pradhan, Efficient and color-tunable Mn-doped ZnSe 
nanocrystal emitters: Control of optical performance via greener synthetic chemistry. 
Journal of the American Chemical Society, 2007. 129(11): p. 3339-3347. 
2. Peng, X.G., et al., Efficient, stable, small, and water-soluble doped ZnSe 
nanocrystal emitters as non-cadmium biomedical labels. Nano Letters, 2007. 7(2): p. 312-
317. 
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Appendix B: Preparing nanoparticles for toxicity assays 
Purpose 
This document describes the procedure to prepare nanoparticles for toxicity study. 
These particles include Mn-doped ZnSe (MPA) QDs, CdSe/ZnS (MPA) QDs, Mn-doped 
ZnSe (PS-PEO) QDs, CdSe/ZnS (PS-PEO) QDs, and empty PS-PEO QDs. 
 
Safety Precautions and PPE: 
 CdSe/ZnS QDs are toxic 
 Mn-doped ZnSe QDs may be toxic 
 3-Mercaptopropionic acid is toxic and corrosive; and it should be and opened in 
fume hood; 
 Acetone, chloroform, isopropanol and methanol are volatile and flammable, and it 
should be stored in flammable cabinet and opened in fume hood; 
 Sodium hydroxide is a strong base and corrosive, and should be handled with care; 
 
PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. Operations should be conducted in a fume hood. 
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Materials 
 Unpurified Mn-doped ZnSe QD stock solution 
 Chloroform 
 Acetone 
 Methanol 
 Isopropanol 
 3-Mercaptopropionic acid 
 octanethiol 
 Polystyrene-polyethylene oxide-COOH (9.5k-b-18k), Polymer Source Inc. 
 Polyvinyl alcohol (13k~23k), Sigma-Aldrich 
 1 M sodium hydroxide (NaOH) 
 DI water 
 70% ethanol 
 Centrifuge tubes 
 100 kDa microcentrifugal filters (Millipore) 
 Syringe and needle 
 0.22 µm filters 
 Water bath 
 Microcentrifuge 
 Bath sonicator 
 UV-vis spectrometer 
 Fluorescence spectrometer  
138 
 
Synthesis of Mn-doped ZnSe (MPA) QDs 
The organic Mn-doped ZnSe synthesis procedure was described in a separate SOP, 
and the phase transfer methods were modified. 
1. Warm up Mn-doped ZnSe QD stock solution in 37 ˚C water bath, and take 100 µl 
of the solution to a 1.5 ml centrifuge tube 
2. Add 100 µl chloroform to the QD stock solution, and put the mixture in 70 ˚ C water 
bath for 2 minutes 
3. Add 200 µl acetone to the mixture, and briefly stir the solution (acetone density is 
much lower than chloroform, and insufficient mixing may reduce purification 
efficiency). Put the mixture in 70 ˚C water bath for 2 minutes 
4. Quickly transfer the tube to a microcentrifuge and centrifuge at 20817 rcf (max 
speed) for 20 seconds. (Note: impurities may precipitate from the supernatant after 
the centrifuge, do NOT centrifuge again). Carefully remove the supernatant 
5. Repeat step 2-4 for twice, and finally dissolve the product in 300 µl chloroform 
6. Add 30 µl of 3-Mercaptopropionic acid to the solution, mix well, and sonicate for 
1 hour. 
7. Centrifuge the vial at 7000 rcf for 1 min, and carefully remove the supernatant 
(Note: it is important to remove all the liquid at the bottom. After removing the 
majority of the supernatant, wait for ~ 1 min, and there may be a small amount of 
liquid accumulated at the bottom, use a finer pipette tip to remove the liquid). 
8. Suspend the pellet in 300 µl chloroform, and repeat step 7 
9. Add 500 µl DI water and 5 µl 1 M NaOH solution to dissolve the pellet 
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10. Wash the solution twice with filter centrifuge (100kDa, 7000 rcf, 1 min each wash) 
11. Pass the solution through a 0.22 µm filter to sterilize the sample, and measure the 
concentration by UV-vis spectrometer (1 mg/ml QD has absorbance at 440 nm of 
0.127), and dilute to the right concentration with sterile water. 
 
Synthesis of CdSe/ZnS (MPA) QDs 
The organic CdSe/ZnS (max emission = 605 nm) is purchased from Life 
Technologies, and the solution was dispensed in decane. 
1. Transfer 400 µl of QD stock solution, centrifuge at 1000 rcf for 3 min to remove 
aggregates 
2. Prepare 3 centrifuge tubes, and in each mix 150 µl of isopropanol and 300 µl of 
methanol 
3. Add 100 µl QD to each vial, mix well, and centrifuge at 1000 rcf for 4 min to 
precipitate QDs 
4. Remove the supernatant, add 100 µl of chloroform to dissolve the QDs, and 
combine these QDs in one vial 
5. Add 30 µl of 3-Mercaptopropionic acid to the solution, mix well, and sonicate for 
1 hour. 
6. Centrifuge the vial at 7000 rcf for 1 min, and carefully remove the supernatant 
(Note: it is important to remove all the liquid at the bottom. After removing the 
majority of the supernatant, wait for ~ 1 min, and there may be a small amount of 
liquid accumulated at the bottom, use a finer pipette tip to remove the liquid). 
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7. Suspend the pellet in 300 µl chloroform, and repeat step 7 
8. Add 500 µl DI water and 5 µl 1 M NaOH solution to dissolve the pellet 
9. Wash the solution 3 times with filter centrifuge (100kDa, 7000 rcf, 1 min each 
wash) 
10. Pass the solution through a 0.22 µm filter to sterilize the sample, and measure the 
concentration by UV-vis spectrometer (50 nM (~16.7 µg/ml) QD has absorbance 
at 400 nm of 0.328), and dilute to the right concentration with sterile water. 
 
Synthesis of Mn-doped ZnSe (micelle) QDs 
The organic Mn-doped ZnSe synthesis procedure was described in a separate SOP, 
and the phase transfer methods were modified. 
1. Warm up Mn-doped ZnSe QD stock solution in 37 ˚C water bath, and take 100 µl 
of the solution to a 1.5 ml centrifuge tube 
2. Add 100 µl chloroform to the QD stock solution, and put the mixture in 70 ˚ C water 
bath for 2 minutes 
3. Add 200 µl acetone to the mixture, and briefly stir the solution (acetone density is 
much lower than chloroform, and insufficient mixing may reduce purification 
efficiency). Put the mixture in 70 ˚C water bath for 2 minutes 
4. Quickly transfer the tube to a microcentrifuge and centrifuge at 20817 rcf (max 
speed) for 20 seconds. (Note: impurities may precipitate from the supernatant after 
the centrifuge, do NOT centrifuge again). Carefully remove the supernatant 
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5. Repeat step 2-4 for twice, and finally dissolve the product in 300 µl chloroform 
6. Add 30 µl of 1-octanethiol to the solution, mix well, and sonicate for 1 hour. 
7. Add 600 µl of acetone to precipitate the QDs, and centrifuge at 20,817 rcf for 2 min 
to remove the supernatant. (Note: it is important to remove all the liquid at the 
bottom. After removing the majority of the supernatant, wait for ~ 1 min, and there 
may be a small amount of liquid accumulated at the bottom, use a finer pipette tip 
to remove the liquid). 
8. Suspend the pellet in 300 µl chloroform, and repeat step 7 
9. Finally dissolve the QDs in chloroform at ~ 0.7 mg/ml (1 mg/ml QD has absorbance 
at 440 nm of 0.127) 
10. Mix 50 µl QD and 10 µl PS-PEO chloroform solution (20 mg/ml) in a 50 ml 
centrifuge tube, and add 3 ml PVA (5 mg/ml) to form an emulsion. 
11. The emulsion is then transferred to a bath sonicator, and after 2 min, start blowing 
air on top of the solution (do NOT directly bubbling air into the emulsion). The 
solution becomes transparent in 10 mins. 
12. Pass the solution through a 0.22 µm filter to sterilize the sample, and measure the 
fluorescence change before and after the filtration to determine the concentration 
(assuming no loss during phase transfer). 
13. Sterile two 100kDa filter (capacity = 15 ml) with 70% ethanol, rinse twice with 
sterile water. Dilute the micelle solution 10 times and use the filter to remove PVA 
with 1000 rcf, 5 min wash, 5 times. 
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Synthesis of CdSe/ZnS (micelle) QDs 
The organic CdSe/ZnS (max emission = 605 nm) is purchased from Life 
Technologies, and the solution was dispensed in decane. 
1. Transfer 400 µl of QD stock solution, centrifuge at 1000 rcf for 3 min to remove 
aggregates 
2. Prepare 3 centrifuge tubes, and in each mix 150 µl of isopropanol and 300 µl of 
methanol 
3. Add 100 µl QD to each vial, mix well, and centrifuge at 1000 rcf for 4 min to 
precipitate QDs 
4. Remove the supernatant, add 100 µl of chloroform to dissolve the QDs. 
5. Add 150 µl of isopropanol and 300 µl of methanol to the vial, mix well, and 
centrifuge at 20,817 rcf for 1 min to precipitate the QDs 
6. Add 50 µl chloroform to each vial, and combine the QDs and measure the solution. 
Bring the solution to 0.35 mg/ml by adding more chloroform (50 nM (~16.7 µg/ml) 
QD has absorbance at 400 nm of 0.328) 
7. Transfer 100 µl QD and 10 µl PS-PEO solution (20 mg/ml) to a 15 ml centrifuge 
tube, and add 3 ml PVA (5 mg/ml) 
8. The emulsion is then transferred to a bath sonicator for 1 h. 
9. Pass the solution through a 0.22 µm filter to sterilize the sample, and measure the 
fluorescence change before and after the filtration to determine the concentration 
(assuming no loss during phase transfer). 
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10. Sterile two 100kDa filter (capacity = 15 ml) with 70% ethanol, rinse twice with 
sterile water. Dilute the micelle solution 10 times and use the filter to remove PVA 
with 1000 rcf, 5 min wash, 5 times. 
 
Synthesis of empty micelle 
1. Transfer 100 µl chloroform and 10 µl PS-PEO solution (20 mg/ml) to a 15 ml 
centrifuge tube, and add 3 ml PVA (5 mg/ml) 
2. The emulsion is then transferred to a bath sonicator for 1 h. 
3. Pass the solution through a 0.22 µm filter to sterilize the sample, and assume 
average loss of empty micelle the same as CdSe/ZnS micelles 
4. Sterile two 100kDa filter (capacity = 15 ml) with 70% ethanol, rinse twice with 
sterile water. Dilute the micelle solution 10 times and use the filter to remove PVA 
with 1000 rcf, 5 min wash, 5 times. 
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Appendix C: Chloroform concentration determination assay 
Purpose 
This document describes the procedure to determine the concentration of remaining 
chloroform in an aqueous solution. The assay was adapted from a qualitative assay from 
reference [1]. 
 
Safety Precautions and PPE 
 Chloroform and pyridine are volatile and flammable, and should be stored in 
flammable cabinet and opened in fume hood;  
 50% sodium hydroxide is corrosive, and should be handled with care. 
PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. Operations should be conducted in a fume hood. 
 
Materials 
 Chloroform 
 Pyridine 
 DI water 
 50% NaOH solution 
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 UV-vis spectrometer 
 Microcentrifuge 
 
Procedure 
1. Prepare calibration chloroform solutions: water, 20 PPM, 40 PPM, 60 PPM, 80 
PPM, 100 PPM 
2. For each sample, take 300 µl and mix with 200 µl NaOH (50%) solution, and add 
250 µl pyridine 
3. Place all the vials in one floating rack, and vortex at 2000 rpm for 1 min. [Note: it 
is critical to make calibration curve each time, and vortex them at the same time 
and speed, otherwise a huge standard deviation will be introduced. Placing all the 
vials in the same rack is helpful to minimize the standard deviation caused by 
uneven vortex and/or heating] 
4. Place the floating rack in preheated 90 ˚C water bath for 2 min 
5. Cool the vials in room temperature water bath for 3 min 
6. Centrifuge the solution at 1000 rcf for 1 min to cause phase separation 
7. Take 50 µl of the pyridine layer, and add 150 µl pyridine, and centrifuge at 20817 
rcf for 3 min [Note: after the phase transfer, the pyridine layer may still be 
oversaturated. This step ensure the sample is transparent (no scattering) when 
measured with UV-vis spectrometer] 
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8. Measure UV-vis spectra, and take the absorbance at 540 nm for each sample. 
Generate a calibration curve (linear fit) and use it to determine the chloroform 
concentration in the unknown sample. 
Reference 
1. Ross, J.H., A color test for chloroform and chloral hydrate. Journal of Biological 
Chemistry, 1923. 58(2): p. 641-642. 
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Appendix D: MTT assay for nanoparticles 
Purpose 
This protocol describes the detailed procedure of MTT assay for nanoparticles 
 
Safety Precautions and PPE: 
 Nanoparticle samples include cadmium based quantum dots, and should be handled 
with care 
PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. 
 
Materials 
 Sterile nanoparticle samples prepared in water 
 HepG2 cells 
 MTT assay kit (Life Technologies V-13154) 
 Minimum Essential Medium (MEM) powder (Sigma-Aldrich M0268) 
 Phenol red free MEM medium (liquid) 
 Fetal bovine serum (FBS) 
 Penicillin-Streptomycin (10,000 U/mL) (Life Technologies, 15140) 
 MycoZap antibiotics 
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 Sodium bicarbonate  
 M HCl 
 Phosphate-buffered saline (PBS), sterile 
 0.22 µm filters 
 96-well plates (cell culture treated, flat bottom, sterile, transparent) 
 
Preparation: 
1. For cell growth medium: prepare 9.7 g MEM powder and 2.2 g sodium bicarbonate 
in 1 L DI water, and add 100 ml FBS, 10 ml Penicillin-Streptomycin, 2 ml 
MycoZap antibotics, and filter through a 0.22 µm filter. 
2. For MTT phenol red free medium, mix 1 L Phenol red free MEM medium with 100 
ml FBS, 10 ml Penicillin-Streptomycin, 2 ml MycoZap antibotics, and filter 
through a 0.22 µm filter. 
3. During micelle preparation, it is important to avoid over concentrate the samples, 
therefore, concentrated medium will be added the nanoparticle solution instead of 
adding concentrated micelle samples to standard cell medium. Concentrated 
medium is prepared as follow: mix 1 ml 10X MEM solution (97 g/L), 1 ml 10X 
sodium bicarbonate (22 g/L), 1 ml FBS, 0.1 ml Penicillin-Streptomycin, and 0.2 ml 
MycoZap antibotics. Sterile the medium before adding to the nanoparticle samples. 
4. Prepare the nanoparticle to 1.4X of the final testing concentration, mix the solution 
and the concentrated medium with 5: 2 ratio (prepared prior to adding the particle 
to the cells during the assay) 
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5. For cell culture, HepG2 cells were feed every other day, and passaged to a new 
plate at ~ 80% confluency with standard cell passage protocols 
 
MTT assay 
1. Seed the cells at 5000 cells per well (100 µl of 50000 cells/ml suspension) in a 96 
well plates (plan 5 wells with no cells as blank). It is important not to use the wells 
on the edge, because solution in these wells tend to evaporate faster and may cause 
large standard deviation. These wells should be filled with water. For the following 
steps, treat the blank well the same as sample wells. 
2. After 24 hours incubation in 37 ˚C, the cell medium is carefully removed by 
pipetting. Note it is important not to use vacuum to remove the medium to avoid 
loss of cells. 
3. Add 50 µl of the prepared nanoparticle samples are added to the wells. Each 
concentration should have 5 replica (including control), and the sequence should 
be randomized. 
4. After 24 hours incubation in 37 ˚C, the nanoparticles are carefully removed by 
pipetting, and 100 µl of phenol red medium is added to each well 
5. Prepare 5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide) in sterile PBS (use sonicator or mild heating to facilitate dissolving). Note 
that if there is insoluble solid, first centrifuge the vial and only use the supernatant. 
6. Add 10 µl MTT solution to each well, and incubate 4 hours in 37 ˚C. 
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7. Add 10 ml 0.01 M HCl to dissolve 1 g of SDS (sodium dodecyl sulfate) 
8. Add 100 µl SDS solution to each well after 4 hours, and incubate overnight. 
9. Measure absorbance at 570 nm with a microplate reader. It is important to make 
sure there is no air bubbles on top of the solution (blow hot air to remove the air 
bubble). Also, make sure the purple precipitate at the bottom has been fully 
dissolved (incubate longer in 37 ˚C if not fully dissolved). 
10. Cell viability is calculated by: 
Viability =  
ABSsample − ABSBlank
ABScontrol − ABSBlank
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Appendix E: ROS assay for nanoparticles 
Purpose 
This protocol describes the detailed procedure of ROS assay for nanoparticles 
 
Safety Precautions and PPE: 
 Nanoparticle samples include cadmium based quantum dots, and should be handled 
with care 
PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. 
 
Materials 
 Sterile nanoparticle samples prepared in water 
 HepG2 cells 
 ROS assay kit (Life Technologies C10444) 
 Minimum Essential Medium (MEM) powder (Sigma-Aldrich M0268) 
 Fetal bovine serum (FBS) 
 Penicillin-Streptomycin (10,000 U/mL) (Life Technologies, 15140) 
 MycoZap antibiotics 
 Sodium bicarbonate  
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 Phosphate-buffered saline (PBS), sterile 
 Menadione 
 Dimethyl sulfoxide (DMSO) 
 0.22 µm filters 
 96-well plates (cell culture treated, flat bottom, sterile, black) 
 
Preparation 
1. For cell growth medium: prepare 9.7 g MEM powder and 2.2 g sodium bicarbonate 
in 1 L DI water, and add 100 ml FBS, 10 ml Penicillin-Streptomycin, 2 ml 
MycoZap antibotics, and filter through a 0.22 µm filter. 
2. During micelle preparation, it is important to avoid over concentrate the samples, 
therefore, concentrated medium will be added the nanoparticle solution instead of 
adding concentrated micelle samples to standard cell medium. Concentrated 
medium is prepared as follow: mix 1 ml 10X MEM solution (97 g/L), 1 ml 10X 
sodium bicarbonate (22 g/L), 1 ml FBS, 0.1 ml Penicillin-Streptomycin, and 0.2 ml 
MycoZap antibotics. Sterile the medium before adding to the nanoparticle samples. 
3. Prepare the nanoparticle to 1.4X of the final testing concentration, mix the solution 
and the concentrated medium with 5: 2 ratio (prepared prior to adding the particle 
to the cells during the assay) 
4. For cell culture, HepG2 cells were feed every other day, and passaged to a new 
plate at ~ 80% confluency with standard cell passage protocols. 
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ROS assay 
1. Seed the cells at 20k cells per well (100 µl of 200k cells/ml suspension) in a 96 well 
plates. It is important not to use the wells on the edge, because solution in these 
wells tend to evaporate faster and may cause large standard deviation. These wells 
should be filled with water (used as blank). 
2. After 24 hours incubation in 37 ˚C, the cell medium is carefully removed by 
pipetting. Note it is important not to use vacuum to remove the medium to avoid 
loss of cells. 
3. Add 50 µl of the prepared nanoparticle samples are added to the wells. Each 
concentration should have 5 replica (including negative control and positive 
control), and the sequence should be randomized. 
4. Prepare 100 mM Menadione in DMSO, and dilute to 100 µM with cell medium 
5. After 24 hours incubation in 37 ˚C, carefully replace the medium in the positive 
control wells and add 50 µl of the Menadione solution 
6. Mix 950 µl PBS and 50 µl of ROS dye stock solution. (Note: the ROS dye 
concentration is higher than the instruction to improve signal to noise ratio). 
7. After 1 hour incubation with the Menadione solution, add 5 µl ROS dye solution to 
each well. Do NOT keep the ROS dye solution for next time. 
8. After 0.5 hours incubation in 37 ˚C, carefully remove all the medium, and wash the 
wells with 100 µl PBS twice. 
9. Measure fluorescence under TECAN GENios Pro fluorescence microplate reader 
(excitation = 485 nm, emission = 535 nm, gain = 75, read from bottom). It is 
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important to make sure there is no air bubbles on top of the solution (blow hot air 
to remove the air bubble). 
10. ROS signal is reported after deducting the average of the blank wells (filled with 
water) 
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Appendix F: TUNEL assay for nanoparticles 
Purpose 
This protocol describes the detailed procedure of TUNEL assay for nanoparticles. 
 
Safety Precautions and PPE: 
 Nanoparticle samples include cadmium based quantum dots, and should be handled 
with care 
 Paraformaldehyde is toxic and it is a known carcinogen, and the solution should be 
prepared and used under a fume hood 
PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. 
 
Materials 
 Sterile nanoparticle samples prepared in water 
 HepG2 cells 
 Minimum Essential Medium (MEM) powder (Sigma-Aldrich M0268) 
 Fetal bovine serum (FBS) 
 Penicillin-Streptomycin (10,000 U/mL) (Life Technologies, 15140) 
 MycoZap antibiotics 
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 TUNEL assay kit (Life Technologies C10617): TdT Reaction Buffer (Component 
A); EdUTP nucleotide mixture (Component B); TdT (terminal deoxynucleotidyl 
transferase) (Component C); Click-iT ○R  Plus TUNEL Reaction Buffer, 10X 
(Component D); Click-iT○R  Plus TUNEL Reaction Buffer Additive (Component E); 
Copper protectant (Component F); Alexa Flour○R  picolyl azide dye (Component G); 
Proteinase K (Component H). 
 DNase (Life Technologies 18068-015) 
 Minimum Essential Medium (MEM) powder (Sigma-Aldrich M0268) 
 Fetal bovine serum (FBS) 
 Penicillin-Streptomycin (10,000 U/mL) (Life Technologies, 15140) 
 MycoZap antibiotics 
 Sodium bicarbonate  
 Phosphate-buffered saline (PBS), sterile 
 Paraformaldehyde powder 
 Bovine serum albumin (BSA) 
 Triton-X 100 
 0.22 µm filters 
 96-well plates (cell culture treated, flat bottom, sterile, black) 
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Preparation 
1. For cell growth medium: prepare 9.7 g MEM powder and 2.2 g sodium bicarbonate 
in 1 L DI water, and add 100 ml FBS, 10 ml Penicillin-Streptomycin, 2 ml 
MycoZap antibotics, and filter through a 0.22 µm filter. 
2. During micelle preparation, it is important to avoid over concentrate the samples, 
therefore, concentrated medium will be added the nanoparticle solution instead of 
adding concentrated micelle samples to standard cell medium. Concentrated 
medium is prepared as follow: mix 1 ml 10X MEM solution (97 g/L), 1 ml 10X 
sodium bicarbonate (22 g/L), 1 ml FBS, 0.1 ml Penicillin-Streptomycin, and 0.2 ml 
MycoZap antibotics. Sterile the medium before adding to the nanoparticle samples. 
3. Prepare the nanoparticle to 1.4X of the final testing concentration, mix the solution 
and the concentrated medium with 5: 2 ratio (prepared prior to adding the particle 
to the cells during the assay) 
4. For cell culture, HepG2 cells were feed every other day, and passaged to a new 
plate at ~ 80% confluency with standard cell passage protocols. 
 
TUNEL assay 
1. Prepare the following buffers 
a. 1X Click-iT Plus TUNEL Reaction buffer: transfer all solution D (TUNEL 
reaction buffer) to 4.5 ml water (dilution 10X). 
b. Supermix solution (store in -20 ˚C) 
i. 1X Click-iT Plus: 2630 µl 
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ii. Copper Protectant (Component F): 67 µl 
iii. Alexa Fluor picolyl azide (G): 3.7 µl 
c. 100X TUNEL reaction buffer additive:  component E by adding 2 ml water 
to the vial (400 mg) 
d. 10X TUNEL reaction buffer additive: dilute solution c 10X (prepare prior 
to use) 
e. Click-iT® Plus TUNEL reaction cocktails: 
i. 90% total volume of supermix (each well uses 35 µl of the reaction 
cocktails) 
ii. 10% total volume of 10X additive buffer (step 5.1 above)  
f. Fixative: 4% paraformadehyde in PBS (1% 1M NaOH) 
g. Permeabilization buffer: 0.25% Triton in PBS 
h. BSA-PBS buffer: 3% BSA in PBS 
i. BSA-Triton buffer: 3% BSA and 0.1% Triton® X-100 in PBS 
j. 1X DNase I Reaction Buffer: dilute 10X of the stock buffer provided by 
vendor 
k. DNase I 1X solution (prepare prior to use) 
l. TdT mixture (prepare prior to use) 
i. TdT reaction buffer (A): 94% of total volume (each well uses 35 µl 
TdT mixture) 
ii. EdUTP (B): 2% of total volume 
iii. TdT enzyme C: 4% of total volume 
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2. Seed the cells at 20k cells per well (100 µl of 200k cells/ml suspension) in a 96 well 
plates. It is important not to use the wells on the edge, because solution in these 
wells tend to evaporate faster and may cause large standard deviation. These wells 
should be filled with water (used as blank). 
3. After 24 hours incubation in 37 ˚C, the cell medium is carefully removed by 
pipetting. Note it is important not to use vacuum to remove the medium to avoid 
loss of cells. 
4. Add 50 µl of the prepared nanoparticle samples are added to the wells. Each 
concentration should have 3 replica (including negative control and positive 
control), and the sequence should be randomized. 
5. After 24 hours incubation in 37 ˚C, carefully remove media with pipette, and add 
100 µl fixative for 15 min at room temperature (RT) 
6. Remove fixative, and treat the cells with 100 µl permeabilization buffer for 20 min 
at RT 
7. Wash twice with 50 µl water 
8. Add 50 µl 1X DNase solution to the positive control wells, and incubate at RT for 
30 min; wash the positive control wells with water 
9. Remove the water, and add 35 µl pre-warmed TdT Reaction buffer (component A), 
incubate in 37 ˚C for 10 min 
10. Remove buffer, add 35 µl TdT mixture, incubate at 37C for 60 min 
11. Wash once with DI water 
12. Wash with BSA-Triton for 5 min 
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13. Wash with PBS 
14. Add 35 µl of the Click-iT® Plus TUNEL reaction cocktails, and incubate in 37 ˚C 
for 30 min 
15. Wash with BSA-PBS for 5 min 
16. Wash with PBS 
17. Measure fluorescence under TECAN GENios Pro fluorescence microplate reader 
(excitation = 485 nm, emission = 535 nm, gain = 75, read from bottom). It is 
important to make sure there is no air bubbles on top of the solution (blow hot air 
to remove the air bubble). 
18. TUNEL signal is reported after deducting the average of the blank wells (filled with 
water) 
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Appendix G: QD-DNA (oligo) Conjugation 
Purpose 
This protocol describes the detailed procedure of preparation quantum dots - 
ssDNA conjugation 
 
Safety Precautions and PPE 
 Methanol are volatile and flammable, and it should be stored in flammable cabinet 
and opened in fume hood;  
 Quantum dots are potentially toxic 
PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. 
 
Materials 
 QD525_COOH 8uM, Life Technologies 
 Amine oligo solution (~50uM) 
 Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) 
 N-Hydroxysuccinimide (NHS) 
 Methanol 
 NaHCO3 
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 50 kDa centrifugal filter (Millipore) 
 
Procedure 
1. Mix 7.5 µl QD solution with 4.5 µl methanol; 
2. Prepare 2.2mM EDC stock solution: 34.15mg/ml then dilute 100X with methanol; 
add 1.5 µl to the above mixture; 
3. Prepare 4mM NHS stock solution: 46.04mg/ml then dilute 100X with methanol; 
add 2.0 µl to the above mixture; 
4. Incubate at RT for 0.5h; 
5. Prepare 0.1M NaHCO3 solution; 
6. Add 12 µl oligo solution into 123 µl 0.1M Sodium Phosphate buffer (pH = 8.4); 
7. Mix QD solution and oligo solution (QD: DNA = 1: 10); 
8. Incubate at RT for at least 4 hours; 
9. Purify the particles with 50kDa centrifugal filter at 7,000 rcf, 5 minutes for 3 times 
with water. 
Reference 
[1] Y. Xing, Q. Chaudry, C. Shen, K. Y. Kong, H. E. Zhau, L. WChung, J. A. Petros, 
R. M. O'Regan, M. V. Yezhelyev, J. W. Simons, M. D. Wang, and S. Nie, “Bioconjugated 
quantum dots for multiplexed and quantitative immunohistochemistry,” Nature Protocols, 
2(5), 1152-1165 (2007). 
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Appendix H: AuNP-DNA (oligo) Conjugation 
Purpose 
This protocol describes the detailed procedure of preparation of gold nanoparticle-
DNA conjugates containing many DNA strands per particle.  
 
Safety Precautions and PPE 
 No particular toxic chemicals involved in the procedures 
PPE Recommendations: the operator should wear lab coat, safety glasses, and nitrile or 
latex gloves at all times. 
 
Materials 
Gold nanoparticles (a. Nanocs, GNP01-15-100, 15 nm, 0.01% Au, 100 ml, 2.3nM) 
 DNA oligo (5' modifier = [3THS]) 
 Dithiothreitol (DTT), sigma 
 NaH2PO4 
 Na2HPO4 
 HCl 
 NaCl 
 NAP-10 column (GE healthcare) 
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Step 1: prepare oligo stock solution 
1. Sterilize pipette tips, glass bottles, centrifuge tubes, and water; 
2. Use the sterilized water to dissolve oligo; 
3. Divide the solution to 10 separate vials; 
4. Use one vial to prepare solutions of different concentration, and keep them in -20 
degree C or 4 degree C; 
5. Put 3 vials in -80 freezer; 
6. Dry 6 vials with freeze dryer; and then put in -80 freezer; 
7. Test UV-absorbance, see figure 1. 
 
Step 2: modify THS group 
1. Prepare 0.1M Sodium phosphate (pH = 8.4) buffer by mixing 100mM NaH2PO4 
solution and 100mM Na2HPO4 solution; 
2. Prepare 100mM DTT (MW = 154) solution in the above buffer (77.13 mg DDT, 5 
ml buffer); 
3. Dissolve the non-reduced oligo in 125 µl of 100mM DTT. Incubate the solution at 
room temperature for 2 hours (gentle vortex, speed = 1000 rpm); 
4. Equilibrate a NAP-10 column with approximately 15 ml of DI water. 
5. Add the sample (DTT buffer with oligo) to the NAP-10 column, and add DI water 
for elution; collect samples in different vials for each 0.5 ml solution; usually the 
oligo comes out in the third vial. See figure 2. 
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6. Test absorbance at 260 nm to determine the concentration. The concentration can 
be determined by the following equation: 
concentration =  A260 ∗ 32.875
mg
L
÷ 2,600,000mg/mol 
 
Step 3: AuNP-DNA conjugation 
1. For 15nm gold nanoparticles, each particle can absorb 149 oligo. 
 
A 0.5 times of excess is added to assure successful conjugation. For 1 ml AuNP 
solution (2.3nM), the volume of DNA solution is: 
2.3*149*1.5/concentration*1 ml (concentration in terms of nM) 
Or in other term: V (oligo) = 0.04065/A260 (ml) 
2. Mix desired amount of AuNP solution and oligo solution in a small glass bottle, 
which is covered by foil paper to keep it from light. Incubate the solution for 16h 
in room temperature with slow rotation. (After this step, take a small sample and 
bring it to 0.1M NaCl, if this step is successful, then the red color should remain; if 
not successful, it will become colorless within 1min); 
3. Prepare 1M NaCl solution and 0.1M Sodium Phosphate buffer (pH=7.0); 
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Step 4: Isolate conjugates 
1. Centrifuge the suspension to form a red oil of nanoparticles beneath a clear solution 
of excess oligo. (Failure to form stable nanoparticle-DNA conjugates will result in 
the formation of a solid pellet rather than red oil.)  
2. Carefully remove the clear supernatant and resuspend the oil in the same volume 
of 0.1 M NaCl/10 mM sodium phosphate buffer. 
3. Repeat centrifugation, removal of supernatant, and resuspension twice more, but 
resuspend the last time in 0.3 M NaCl/0.01% sodium azide/10 mM sodium 
phosphate buffer. (3 ml 1M NaCl, 1 ml 100mM sodium phosphate, 0.1 ml 1% 
sodium azide, 5.9 ml DI water) 
 
Step 5: Quantitate and store conjugates 
1. Test absorbance at 520nm, and compare with the original solution (2.3mM). 
2. Store conjugate solution at 4°C in the dark. 
 
Reference: 
[1] J. J. Storhoff, R. Elghanian, R. C. Mucic, C. A. Mirkin, and R. L. Letsinger, “One-
Pot Colorimetric Differentiation of Polynucleotides with Single Base Imperfections Using 
Gold Nanoparticle Probes,” J. Am. Chem. Soc., 120, 1959-1964 (1998). 
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Appendix I: Reprint Permission 
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